WO2009102069A1 - 非対称カーボネート化合物、及びその製造方法 - Google Patents
非対称カーボネート化合物、及びその製造方法 Download PDFInfo
- Publication number
- WO2009102069A1 WO2009102069A1 PCT/JP2009/052586 JP2009052586W WO2009102069A1 WO 2009102069 A1 WO2009102069 A1 WO 2009102069A1 JP 2009052586 W JP2009052586 W JP 2009052586W WO 2009102069 A1 WO2009102069 A1 WO 2009102069A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- general formula
- carbonate compound
- compound represented
- bond
- Prior art date
Links
- -1 carbonate compound Chemical class 0.000 title claims abstract description 230
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 54
- 238000006243 chemical reaction Methods 0.000 claims abstract description 149
- 150000002430 hydrocarbons Chemical group 0.000 claims description 104
- 125000004432 carbon atom Chemical group C* 0.000 claims description 97
- 125000001424 substituent group Chemical group 0.000 claims description 67
- 102000004157 Hydrolases Human genes 0.000 claims description 41
- 108090000604 Hydrolases Proteins 0.000 claims description 41
- 108090001060 Lipase Proteins 0.000 claims description 39
- 239000004367 Lipase Substances 0.000 claims description 39
- 102000004882 Lipase Human genes 0.000 claims description 39
- 125000002947 alkylene group Chemical group 0.000 claims description 39
- 235000019421 lipase Nutrition 0.000 claims description 39
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 33
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 32
- 150000001875 compounds Chemical class 0.000 claims description 31
- 125000005647 linker group Chemical group 0.000 claims description 28
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 18
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 claims description 16
- 239000003960 organic solvent Substances 0.000 claims description 14
- 238000005809 transesterification reaction Methods 0.000 claims description 14
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 12
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 8
- 125000004450 alkenylene group Chemical group 0.000 claims description 8
- VEZXCJBBBCKRPI-UHFFFAOYSA-N beta-propiolactone Chemical compound O=C1CCO1 VEZXCJBBBCKRPI-UHFFFAOYSA-N 0.000 claims description 8
- 229960000380 propiolactone Drugs 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 5
- 108090000371 Esterases Proteins 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 239000004365 Protease Substances 0.000 claims description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 9
- 108090000790 Enzymes Proteins 0.000 abstract description 9
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 2
- 239000000706 filtrate Substances 0.000 description 41
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 34
- 239000000243 solution Substances 0.000 description 33
- 238000004817 gas chromatography Methods 0.000 description 25
- 238000003756 stirring Methods 0.000 description 25
- 238000003786 synthesis reaction Methods 0.000 description 25
- 230000015572 biosynthetic process Effects 0.000 description 23
- 108010084311 Novozyme 435 Proteins 0.000 description 22
- 239000011521 glass Substances 0.000 description 21
- 239000007788 liquid Substances 0.000 description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 238000005160 1H NMR spectroscopy Methods 0.000 description 14
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 14
- 230000000704 physical effect Effects 0.000 description 14
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 12
- LCLOXRAKDJBSMN-UHFFFAOYSA-N pentyl hydrogen carbonate Chemical compound CCCCCOC(O)=O LCLOXRAKDJBSMN-UHFFFAOYSA-N 0.000 description 11
- 238000010813 internal standard method Methods 0.000 description 10
- XRYGAUCYWTXNIT-UHFFFAOYSA-N methyl 6-methoxycarbonyloxyhexanoate Chemical compound COC(=O)CCCCCOC(=O)OC XRYGAUCYWTXNIT-UHFFFAOYSA-N 0.000 description 9
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 8
- 238000004821 distillation Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 125000002993 cycloalkylene group Chemical group 0.000 description 6
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 6
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 4
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 125000003710 aryl alkyl group Chemical group 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 125000002529 biphenylenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C12)* 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 4
- LXYQRHKBVRJPNQ-UHFFFAOYSA-N methyl 3-methoxycarbonyloxypropanoate Chemical compound COC(=O)CCOC(=O)OC LXYQRHKBVRJPNQ-UHFFFAOYSA-N 0.000 description 4
- JEFSZHVYFOFBGT-UHFFFAOYSA-N methyl 5-methoxycarbonyloxypentanoate Chemical compound COC(=O)CCCCOC(=O)OC JEFSZHVYFOFBGT-UHFFFAOYSA-N 0.000 description 4
- 125000004957 naphthylene group Chemical group 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 4
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 4
- XUKSWKGOQKREON-UHFFFAOYSA-N 1,4-diacetoxybutane Chemical compound CC(=O)OCCCCOC(C)=O XUKSWKGOQKREON-UHFFFAOYSA-N 0.000 description 3
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 3
- RCPSBJKGQVGFHE-UHFFFAOYSA-N 2-(2-methoxycarbonyloxyethoxy)ethyl methyl carbonate Chemical compound COC(=O)OCCOCCOC(=O)OC RCPSBJKGQVGFHE-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- MYNUAGYBVSQRFN-UHFFFAOYSA-N 2-ethoxycarbonyloxyethyl ethyl carbonate Chemical compound CCOC(=O)OCCOC(=O)OCC MYNUAGYBVSQRFN-UHFFFAOYSA-N 0.000 description 3
- DOMLQXFMDFZAAL-UHFFFAOYSA-N 2-methoxycarbonyloxyethyl methyl carbonate Chemical compound COC(=O)OCCOC(=O)OC DOMLQXFMDFZAAL-UHFFFAOYSA-N 0.000 description 3
- ULEIFMXQHFDIEP-UHFFFAOYSA-N 3-methoxycarbonyloxypropyl methyl carbonate Chemical compound COC(=O)OCCCOC(=O)OC ULEIFMXQHFDIEP-UHFFFAOYSA-N 0.000 description 3
- CEWBTBRHSLYBJY-UHFFFAOYSA-N 4-methoxycarbonyloxybutyl methyl carbonate Chemical compound COC(=O)OCCCCOC(=O)OC CEWBTBRHSLYBJY-UHFFFAOYSA-N 0.000 description 3
- IBASVVUYCWBJTL-UHFFFAOYSA-N 6-methoxycarbonyloxyhexyl methyl carbonate Chemical compound COC(=O)OCCCCCCOC(=O)OC IBASVVUYCWBJTL-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FMGOMOTWWMFEDE-UHFFFAOYSA-N COC(=O)OCCCCOC(C)=O Chemical compound COC(=O)OCCCCOC(C)=O FMGOMOTWWMFEDE-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 3
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- 238000000023 Kugelrohr distillation Methods 0.000 description 3
- YNCYZSBUDLGGQA-ARJAWSKDSA-N [(z)-4-methoxycarbonyloxybut-2-enyl] methyl carbonate Chemical compound COC(=O)OC\C=C/COC(=O)OC YNCYZSBUDLGGQA-ARJAWSKDSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- RVXBJNBDERKLJG-UHFFFAOYSA-N cyclohexyl methyl carbonate Chemical compound COC(=O)OC1CCCCC1 RVXBJNBDERKLJG-UHFFFAOYSA-N 0.000 description 3
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 125000006839 xylylene group Chemical group 0.000 description 3
- DSVGICPKBRQDDX-UHFFFAOYSA-N 1,3-diacetoxypropane Chemical compound CC(=O)OCCCOC(C)=O DSVGICPKBRQDDX-UHFFFAOYSA-N 0.000 description 2
- VSQSFRDZIRKBEF-UHFFFAOYSA-N 12-acetyloxydodecyl acetate Chemical compound CC(=O)OCCCCCCCCCCCCOC(C)=O VSQSFRDZIRKBEF-UHFFFAOYSA-N 0.000 description 2
- WGLLSSPDPJPLOR-UHFFFAOYSA-N 2,3-dimethylbut-2-ene Chemical group CC(C)=C(C)C WGLLSSPDPJPLOR-UHFFFAOYSA-N 0.000 description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 2
- ZMFWEWMHABZQNB-UHFFFAOYSA-N 6-acetyloxyhexyl acetate Chemical compound CC(=O)OCCCCCCOC(C)=O ZMFWEWMHABZQNB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000589513 Burkholderia cepacia Species 0.000 description 2
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 2
- UDSFAEKRVUSQDD-UHFFFAOYSA-N Dimethyl adipate Chemical compound COC(=O)CCCCC(=O)OC UDSFAEKRVUSQDD-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 241000235403 Rhizomucor miehei Species 0.000 description 2
- VZUAUHWZIKOMFC-ARJAWSKDSA-N [(z)-4-acetyloxybut-2-enyl] acetate Chemical compound CC(=O)OC\C=C/COC(C)=O VZUAUHWZIKOMFC-ARJAWSKDSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 125000006278 bromobenzyl group Chemical group 0.000 description 2
- 125000004799 bromophenyl group Chemical group 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 2
- 125000004803 chlorobenzyl group Chemical group 0.000 description 2
- 125000000068 chlorophenyl group Chemical group 0.000 description 2
- 125000002946 cyanobenzyl group Chemical group 0.000 description 2
- 125000004802 cyanophenyl group Chemical group 0.000 description 2
- 125000004976 cyclobutylene group Chemical group 0.000 description 2
- 125000004980 cyclopropylene group Chemical group 0.000 description 2
- UBPGILLNMDGSDS-UHFFFAOYSA-N diethylene glycol diacetate Chemical compound CC(=O)OCCOCCOC(C)=O UBPGILLNMDGSDS-UHFFFAOYSA-N 0.000 description 2
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 2
- 125000005805 dimethoxy phenyl group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 125000004175 fluorobenzyl group Chemical group 0.000 description 2
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 2
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- GAEKPEKOJKCEMS-UHFFFAOYSA-N gamma-valerolactone Chemical compound CC1CCC(=O)O1 GAEKPEKOJKCEMS-UHFFFAOYSA-N 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 125000006480 iodobenzyl group Chemical group 0.000 description 2
- 125000006303 iodophenyl group Chemical group 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 125000006501 nitrophenyl group Chemical group 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- 125000006000 trichloroethyl group Chemical group 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- ILHLUZUMRJQEAH-UHFFFAOYSA-N 1,4-dihydroisochromen-3-one Chemical compound C1=CC=C2COC(=O)CC2=C1 ILHLUZUMRJQEAH-UHFFFAOYSA-N 0.000 description 1
- IYBOGQYZTIIPNI-UHFFFAOYSA-N 2-methylhexano-6-lactone Chemical compound CC1CCCCOC1=O IYBOGQYZTIIPNI-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical compound O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 1
- ULKFLOVGORAZDI-UHFFFAOYSA-N 3,3-dimethyloxetan-2-one Chemical compound CC1(C)COC1=O ULKFLOVGORAZDI-UHFFFAOYSA-N 0.000 description 1
- YPDDZGPRXUBSCX-UHFFFAOYSA-N 4-ethyloxan-2-one Chemical compound CCC1CCOC(=O)C1 YPDDZGPRXUBSCX-UHFFFAOYSA-N 0.000 description 1
- CHXLFXLPKLZALY-UHFFFAOYSA-N 4-methyloxepan-2-one Chemical compound CC1CCCOC(=O)C1 CHXLFXLPKLZALY-UHFFFAOYSA-N 0.000 description 1
- VNXMFQWTDCWMDQ-UHFFFAOYSA-N 5-methyloxepan-2-one Chemical compound CC1CCOC(=O)CC1 VNXMFQWTDCWMDQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 108010031797 Candida antarctica lipase B Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010048733 Lipozyme Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 125000006003 dichloroethyl group Chemical group 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006001 difluoroethyl group Chemical group 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 125000004914 dipropylamino group Chemical group C(CC)N(CCC)* 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 239000012776 electronic material Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000002638 heterogeneous catalyst Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- FCCDDURTIIUXBY-UHFFFAOYSA-N lipoamide Chemical compound NC(=O)CCCCC1CCSS1 FCCDDURTIIUXBY-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000004372 methylthioethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000005486 organic electrolyte Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Definitions
- the present invention relates to a method for producing an asymmetric carbonate compound by reacting a symmetric carbonate compound and an ester compound.
- the asymmetric carbonate compound is useful as, for example, a fragrance, a non-aqueous organic electrolyte, a solvent, and various organic synthesis reagents (see, for example, Patent Documents 1 to 5).
- Patent Documents 4 and 5 Conventionally, as a method for obtaining an asymmetric carbonate compound, a disproportionation transesterification reaction of two kinds of symmetrical carbonate compounds in the presence of a heterogeneous catalyst is known (for example, see Patent Documents 4 and 5).
- Patent Document 4 the reaction is carried out at a high temperature for a very long time, but the yield is relatively low at 48.8%, and it is difficult to say that the production method is industrially satisfactory.
- the asymmetric carbonate compound can be synthesized using an ester compound as a raw material.
- a method in which a cyclic ester compound and an alcohol compound are reacted in the presence of an acid or a base, and the resulting hydroxyalkanoic acid ester is reacted with a chloroformate in the presence of a tertiary amine to obtain an asymmetric carbonate compound Is known (see, for example, Patent Document 1 and Non-Patent Document 1). However, this method also has many reaction steps, and there is a problem in terms of work and safety in that a haloformate compound such as a chloroformate having toxicity is used.
- Candida antarctica lipase B is a transesterified ⁇ -ketoester from a ⁇ -ketoester compound and an alcohol compound. It is used for the synthesis
- combination of a compound for example, refer patent document 6).
- An object of the present invention is to provide a simple and industrially suitable production method capable of producing an asymmetric carbonate compound with high yield from a symmetric carbonate compound and an ester compound.
- the present inventors can produce a target asymmetric carbonate compound in a high yield by reacting a symmetric carbonate compound and an ester compound in the presence of a hydrolase catalyst.
- the present inventors have found that a suitable manufacturing method can be provided, and have reached the present invention.
- the present invention 1 is a compound represented by the general formula (1) in the presence of a hydrolase: (In the formula, R 1 is the same and represents a monovalent hydrocarbon group which may have a substituent)
- a divalent hydrocarbon group (wherein the hydrocarbon group in Z is interrupted by a linking group selected from the group consisting of an ether bond, a thioether bond, an amide bond, a carbonyl bond and an ester bond). But good) However, R 2 is not the same as R 1 in the general formula (1), and the total number of ester bonds contained in the general formula (2a) is 2 or less.
- This invention 2 is general formula (1) in presence of a hydrolase.
- R 1 is the same and represents a monovalent hydrocarbon group which may have a substituent
- R 2a is not the same as R 1 in the general formula (1), and the total number of ester bonds contained in the general formula (2) is 2 or less.
- Invention 3 is a general formula (4a) in which a reaction between the symmetrical carbonate compound represented by the general formula (1) and the ester compound represented by the general formula (2a) is by-produced by the reaction: (Wherein R 1 and R 3a are as defined in Invention 2)
- the present invention relates to a method for producing an asymmetric carbonate compound of the present invention 2, which is carried out while removing the transesterification compound.
- the present invention 4 relates to the process for producing an asymmetric carbonate compound of the present invention 3, wherein the transesterification compound is distilled off at a reaction pressure of 0.13 kPa or more and less than 101.3 kPa.
- R 1 and R 2a are different from each other and are each a linear alkyl group having 1 to 6 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, or a cycloalkyl having 3 to 6 carbon atoms.
- the present invention relates to a method for producing an asymmetric carbonate compound according to any one of the present inventions 2 to 4, which is an alkyl group.
- the present invention 6 relates to the asymmetric carbonate compound according to any one of the present inventions 2 to 5, wherein R 1 is methyl, ethyl, n-propyl, isopropyl, n-butyl, s-butyl, isobutyl, t-butyl or benzyl. It relates to a manufacturing method.
- R 1 is methyl or ethyl, a method for the preparation of either an asymmetric carbonate compound of the present invention 2-6.
- This invention 8 is general formula (1) in presence of a hydrolase.
- R 1 is the same and represents a monovalent hydrocarbon group which may have a substituent
- R 4a and R 5a are each independently a linear alkyl group having 1 to 6 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, or a group having 3 to 6 carbon atoms.
- the present invention relates to a method for producing a compound.
- This invention 10 is general formula (1) in presence of a hydrolase.
- R 1 is the same and represents a monovalent hydrocarbon group which may have a substituent
- This invention 11 is general formula (1) in presence of a hydrolase:
- R 1 is the same and represents a monovalent hydrocarbon group which may have a substituent
- the present invention 12 is a compound represented by the general formula (1): (In the formula, R 1 is the same and represents a monovalent hydrocarbon group which may have a substituent) A symmetric carbonate compound represented by the general formula (10): [Wherein Z is a divalent hydrocarbon group which may have a substituent (wherein the hydrocarbon group is selected from the group consisting of an ether bond, a thioether bond, an amide bond, a carbonyl bond and an ester bond) However, the total number of ester bonds included in the general formula (10) is 2 or less.
- the present invention 13 relates to the method for producing an asymmetric carbonate compound of the present invention 12, wherein the cyclic ester compound represented by the general formula (10) is ⁇ -valerolactone, ⁇ -propiolactone or ⁇ -caprolactone.
- the present invention 14 relates to the method for producing an asymmetric carbonate compound according to any one of the present inventions 1 to 13, wherein the hydrolase is at least one hydrolase selected from the group consisting of protease, esterase and lipase.
- This invention 15 is related with the manufacturing method of the asymmetric carbonate compound of this invention 14 whose hydrolase is lipase.
- the present invention 16 relates to a method for producing an asymmetric carbonate compound of the present invention 15, wherein the hydrolase is a lipase originating from Candida antarctica.
- the present invention 17 relates to a method for producing an asymmetric carbonate compound according to any one of the present inventions 1 to 16, wherein an organic solvent is used.
- the present invention 18 relates to the process for producing an asymmetric carbonate compound of the present invention 17, wherein the organic solvent is at least one organic solvent selected from the group consisting of cyclohexane, toluene and t-butyl methyl ether.
- the amount of the symmetric carbonate compound represented by the general formula (1) is 0.1 to 100 mol with respect to 1 mol of the ester compound represented by the general formula (2). To any one of the asymmetric carbonate compounds.
- the present invention 20 relates to the process for producing an asymmetric carbonate compound according to any one of the present inventions 1 to 19, wherein the reaction temperature is 0 to 130 ° C.
- the present invention 21 is a compound represented by the general formula (3a): Wherein R 1 and R 2a are as defined above. It is related with the asymmetric carbonate compound shown by these.
- This invention 22 is manufactured by the method of this invention 8 or 9, General formula (6a): (Wherein R 6 is R 4a or R 5a ; R 1 , X are R 4a and R 5a are as defined above) It is related with the asymmetric carbonate compound shown by these.
- This invention 23 is manufactured by the method of this invention 10, General formula (7a): Wherein R 1 and X are as defined above. It is related with the asymmetric carbonate compound shown by these.
- This invention 24 manufactures by the method of this invention 11, General formula (9a): (Wherein R 10a is R 7a or R 8a ; R 1 , R 7a and R 8a are as defined above) It is related with the asymmetric carbonate compound shown by these.
- This invention 25 is manufactured by the method of this invention 12 or 13, General formula (11): (In the formula, R 1 and Z are as defined above, R 1 is the same in the general formula (11)) about the asymmetric carbonate compound represented by the.
- an asymmetric carbonate compound can be produced in good yield from a symmetrical carbonate compound represented by the general formula (1) and an ester compound represented by the general formula (2) by a simple and industrially suitable method. .
- the transesterification compound represented by the general formula (4a) produced as a by-product when the ester compound represented by the general formula (2a) is used as a raw material is the raw material. It may have a low boiling point with respect to the symmetric carbonate compound and the ester compound and the product asymmetric carbonate compound. Therefore, in the present invention, a method for producing a transesterification compound represented by the general formula (4a) as a by-product while removing it from the reaction system has also been found. In the method further including the step of removing the transesterification compound represented by the general formula (4a), the reaction proceeds promptly, so that the target asymmetric carbonate compound can be obtained in a short reaction time.
- an asymmetric carbonate compound is produced using a hydrolase, there is a possibility of contamination with impurities such as metal salts or halides that may occur in products using an asymmetric carbonate compound obtained by a conventional production method. Can provide a chemically safer product with an extremely low. That is, when the asymmetric carbonate compound obtained by the production method of the present invention is used in, for example, a non-aqueous organic electrolytic solution or a solvent for producing electrical and electronic materials, the electrical characteristics associated with halogen ions and metal ions generated from the product. Since the decrease can be suppressed, the production method of the present invention is very excellent.
- an asymmetric carbonate compound represented by the general formula (3) is obtained by reacting a carbonate compound represented by the general formula (1) with an ester compound represented by the general formula (2) in the presence of a hydrolase. (Reaction formula [I]).
- R 1 , R 2 , R 2 ′ and R 3 are as defined above.
- R 1 represents a monovalent hydrocarbon group which may have a substituent.
- R 1 is the same.
- the hydrocarbon group in R 1 is, for example, a linear alkyl group having 1 to 20 carbon atoms such as a methyl group, an ethyl group, a propyl group, a butyl group, a pentyl group or a hexyl group; a carbon such as an isopropyl group or an isobutyl group.
- Examples thereof include aryl groups of 6 to 20. These groups include various isomers.
- the hydrocarbon group for R 1 is preferably a linear alkyl group having 1 to 6 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, a carbon atom An aralkyl group and a phenyl group having 7 to 12 carbon atoms; more preferably, a linear alkyl group having 1 to 4 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, and 3 to 6 carbon atoms.
- a cycloalkyl group, a benzyl group and a phenyl group are particularly preferred are a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group, a t-butyl group, a benzyl group and a phenyl group. These groups include various isomers.
- the hydrocarbon group in R 1 may have a substituent.
- substituents include a halogen atom (fluorine atom, chlorine atom, bromine atom, iodine atom), methoxy group, ethoxy group, propoxy group, An alkyl group having 1 to 6 carbon atoms such as a butoxy group, an alkylthio group having 1 to 6 carbon atoms, an alkoxy group, a dimethylamino group, a diethylamino group, a dipropylamino group, etc. Examples thereof include a disubstituted amino group, a cyano group, a nitro group, and an acyl group such as an acetyl group. There can be one or more substituents.
- R 1 is preferably a linear alkyl group having 1 to 6 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, or 7 to 12 carbon atoms.
- Aralkyl group phenyl group; fluoromethyl group, difluoromethyl group, trifluoromethyl group, chloromethyl group, dichloromethyl group, trichloromethyl group, cyanomethyl group, nitromethyl group, fluoroethyl group, difluoroethyl group, trifluoroethyl group Halogen atoms such as perfluoroethyl group, chloroethyl group, dichloroethyl group, trichloroethyl group, cyanoethyl group, nitroethyl group, methoxyethyl group, ethoxyethyl group, t-butoxyethyl group, methylthioethyl group, ethylthioethyl group, Cyano group, nitro group, alkoxy group having 1 to 6 carbon atoms or carbon A linear alkyl group having 1 to 6 carbon atoms or a branched alkyl group having 3 to
- R 1 is more preferably a linear alkyl group having 1 to 6 carbon atoms, a branched alkyl group having 3 to 6 carbon atoms, a cycloalkyl group having 3 to 6 carbon atoms, a benzyl group, and Phenyl group, fluoromethyl group, difluoromethyl group, trifluoromethyl group, cyanomethyl group, nitromethyl group; fluoroethyl group, trifluoroethyl group, trichloroethyl group, cyanoethyl group, nitroethyl group, methoxyethyl group, ethoxyethyl group, t -Butoxyethyl group, fluorophenyl group, chlorophenyl group, bromophenyl group, iodophenyl group, methoxyphenyl group, dimethoxyphenyl group, ethoxyphenyl group, t-butoxyphenyl group, nitrophen
- R 2 and R 3 are each independently a monovalent hydrocarbon group which may have a substituent (wherein the hydrocarbon group in R 2 and R 3 is an ether Or may be interrupted by a linking group selected from the group consisting of a bond, a thioether bond, an amide bond, a carbonyl bond and an ester bond), or R 2 and R 3 are Z bonded together.
- Z is a divalent hydrocarbon group which may have a substituent (wherein the hydrocarbon group in Z is selected from the group consisting of an ether bond, a thioether bond, an amide bond, a carbonyl bond and an ester bond)
- R 2 is not the same as R 1 in the general formula (1), and the number of ester bonds included in the general formula (2) is 2 or less.
- Hydrocarbon group in R 2 and R 3 may have a substituent, in the specific examples and preferred examples of the substituent are the same as specific examples and preferred examples of substituents for R 1.
- hydrocarbon group having a substituent for R 2 and R 3 are the same as the specific examples and preferred examples of the hydrocarbon group having a substituent for R 1 .
- the hydrocarbon group in R 2 and R 3 includes an ether bond (—O—), a thioether bond (—S—), an amide bond (—CONH—), a carbonyl bond (—C ( ⁇ O) —) and an ester bond ( It may be interrupted by a linking group selected from the group consisting of —C ( ⁇ O) —O—).
- “may be interrupted by a linking group” means that the linking group exists so as to interrupt the hydrocarbon group.
- the hydrocarbon group interrupted by the linking group may further have a substituent.
- examples thereof include a hydrocarbon group interrupted by an ester bond and an ether bond, a thioether bond, an amide bond or a carbonyl bond, such as an ester bond and an ether bond.
- the ester compound of the general formula (2) includes the ester compound of the general formula (2a).
- an asymmetric carbonate compound represented by the general formula (3a) and a general formula (4a) are obtained by reacting the carbonate compound represented by the general formula (1) with the ester compound represented by the general formula (2a).
- a transesterification compound represented by formula (II) is formed (reaction formula [II])
- R 1 , R 2a and R 3a are as defined above.
- R 2a and R 3a are each independently a monovalent hydrocarbon group which may have a substituent (wherein the hydrocarbon group in R 2 and R 3 is an ether R 2a may be the same as R 1 in the general formula (1), which may be interrupted by a linking group selected from the group consisting of a bond, a thioether bond, an amide bond, a carbonyl bond and an ester bond. However, the total number of ester bonds contained in the general formula (2a) is 2 or less.
- the hydrocarbon group, the substituent and the hydrocarbon group having a substituent in R 2a are the same as the specific examples and preferred examples relating to R 1 .
- the hydrocarbon group interrupted by the linking group in R 2a is the same as the specific examples and preferred examples related to R 2 .
- the hydrocarbon group interrupted by the linking group may further have a substituent.
- the hydrocarbon group, the substituent and the hydrocarbon group having a substituent in R 3a are the same as the specific examples and preferred examples relating to R 1 .
- the hydrocarbon group interrupted by the linking group in R 3a is the same as the specific examples and preferred examples related to R 3 .
- the hydrocarbon group interrupted by the linking group may further have a substituent.
- R 3a may be the same as or different from R 1 in the general formula (1).
- General formula (2) includes general formula (5a).
- an asymmetric carbonate compound represented by the general formula (6a) is produced by a reaction between the carbonate compound represented by the general formula (1) and the ester compound represented by the general formula (5a) (reaction formula). [III]).
- the asymmetric carbonate compound represented by the general formula (7a) is further reacted with the compound represented by the general formula (1) in the presence of a hydrolase. A carbonate compound can also be obtained.
- the asymmetric carbonate compound represented by the general formula (6a) is also included in the general formula (2). Further, the produced asymmetric carbonate compound represented by the general formula (6a) is continuously isolated and purified, and the carbonate compound represented by the general formula (1) and the ester compound represented by the general formula (5a) Can be reacted directly to obtain an asymmetric carbonate compound represented by the general formula (7a).
- R 1 , R 4a , R 5a , X and R 6a are as defined above.
- R 4a and R 5a are each independently a monovalent hydrocarbon group which may have a substituent.
- R 4a and R 5a are preferably the same.
- Hydrocarbon group for R 4a for the hydrocarbon group having a substituent and substituents are the same as specific examples and preferred examples of R 1.
- R 4a may be the same as R 1 in the general formula (1), it may be different.
- the hydrocarbon group, the substituent, and the hydrocarbon group having a substituent in R 5a are the same as the specific examples and preferred examples related to R 1 .
- R 5a may be the same as or different from R 1 in the general formula (1).
- the hydrocarbon group in X is, for example, a linear alkylene group having 1 to 20 carbon atoms such as a methylene group, an ethylene group, a propylene group, a butylene group, a pentamethylene group or a hexamethylene group; a carbon such as a tetramethylethylene group.
- a hydrocarbon group having 5 to 24 carbon atoms eg, an alkylene-cycloalkylene-alkylene group
- an unsaturated hydrocarbon group having 2 to 20 carbon atoms containing one or more ethylenically unsaturated bonds For example, an alkenylene group having 2 to 20 carbon atoms (eg, vinylene group), an alkadienylene group having 4 to 20 carbon atoms (for example, , Butadienylene group)); an aromatic skeleton, a hydrocarbon group having 7 to 20 carbon atoms (e.g., alkylene - arylene (eg, C 1 ⁇ 14 alkylene
- X is preferably a linear alkylene group having 1 to 20 carbon atoms; a branched alkylene group having 3 to 6 carbon atoms; a cycloalkylene group having 3 to 6 carbon atoms; one or more ethylenic groups.
- An unsaturated hydrocarbon group having 2 to 12 carbon atoms for example, an alkenylene group having 2 to 6 carbon atoms (for example, vinylene group), an alkadienylene group having 4 to 12 carbon atoms (for example, butadienylene group) )
- a hydrocarbon group containing 7-12 carbon atoms eg, alkylene-arylene (eg, C 1 -C 6 alkylene-phenylene), alkylene-arylene-alkylene (eg, C 1 -C) containing an aromatic skeleton) 3 alkylene-phenylene-C 1 -C 3 alkylene (eg, xylylene group)).
- Examples of the substituent of the hydrocarbon group in X include the same groups as the substituent of the hydrocarbon group in R 1 .
- X having a substituent is preferably a linear alkylene group having 1 to 6 carbon atoms, a branched alkylene group having 3 to 6 carbon atoms, or a 3 to 6 carbon atom group substituted with a halogen atom.
- the hydrocarbon group in X may be interrupted by a linking group selected from the group consisting of an ether bond, a thioether bond, an amide bond and a carbonyl bond. There may be one or more linking groups.
- X that is interrupted by a linking group is preferably: A straight-chain alkylene group having 2 to 6 carbon atoms or a branched alkylene group having 3 to 6 carbon atoms interrupted by an ether bond, or a phenylene group, naphthylene group or biphenylene interrupted by an ether bond
- a hydrocarbon group consisting of a straight chain alkylene group having 1 to 6 carbon atoms or a branched alkylene group having 3 to 6 carbon atoms eg, alkylene-O-arylene (eg, C 1 -C 6 alkylene- O-phenylene)
- X is more preferably a linear alkylene group having 1 to 20 carbon atoms; a branched alkylene group having 3 to 6 carbon atoms; a cycloalkylene group having 3 to 6 carbon atoms; and 2 to 6 carbon atoms. Or a straight chain alkylene group having 1 to 6 carbon atoms or a branched alkylene group having 3 to 6 carbon atoms interrupted by an ether bond, and particularly preferably 1 to 20 carbon atoms.
- a linear alkylene group having 3 to 6 carbon atoms, an alkenylene group having 2 to 6 carbon atoms, or a linear alkylene group having 2 to 6 carbon atoms interrupted by an ether bond. Can be mentioned. These groups include various isomers.
- the ester compound represented by the general formula (5a) is the same as the reaction formula [III].
- the compound of the general formula (2) includes the compound of the general formula (8a).
- an asymmetric carbonate compound represented by the general formula (9a) and a general formula (12a) are obtained by reacting the carbonate compound represented by the general formula (1) with the ester compound represented by the general formula (8a). Is produced
- R 9a is R 7a or R 8a and R 1 , R 7a , R 8a , Y and R 10a are as defined above.
- R 7a and R 8a are each independently a monovalent hydrocarbon group which may have a substituent.
- R 7a and R 8a are preferably the same.
- R 7a The hydrocarbon group of R 7a, the hydrocarbon group having a substituent and substituents are the same as specific examples and preferred examples of R 1.
- R 7a may be the same as or different from R 1 in the general formula (1).
- R 8a The hydrocarbon group, substituent, and hydrocarbon group having a substituent in R 8a are the same as the specific examples and preferred examples of R 1 .
- R 8a may be the same as or different from R 1 in the general formula (1).
- the compound of general formula (2) includes the compound of general formula (10).
- an asymmetric carbonate compound represented by the general formula (11) is produced by a reaction between the carbonate compound represented by the general formula (1) and the cyclic ester compound represented by the general formula (10) (reaction).
- Formula [VI] ).
- the hydrocarbon group in Z is, for example, a linear alkylene group having 1 to 12 carbon atoms such as methylene group, ethylene group, propylene group, butylene group, pentamethylene group, hexamethylene group; A branched alkylene group having 3 to 12 carbon atoms such as tetramethylethylene group; a cycloalkylene group having 3 to 12 carbon atoms such as cyclopropylene group, cyclobutylene group, cyclopentamethylene group and cyclohexamethylene group; vinylene An alkenylene group having 2 to 12 carbon atoms such as a group; for example, an unsaturated hydrocarbon group having 2 to 12 carbon atoms (for example, 2 carbon atoms) which gives a compound such as 2-pyrone as the general formula (10) An alkenylene group of 6 to 6 (eg, vinylene group), an alkadienylene group of 4 to 12 carbon atoms (eg, butadien
- the hydrocarbon group in Z may be interrupted by a linking group selected from the group consisting of an ether bond, a thioether bond, an amide bond, a carbonyl bond and an ester bond. Moreover, the hydrocarbon group in Z may have a substituent. Substituents include the same groups as substituents in R 1.
- Examples of cyclic ester compounds represented by the general formula (10) include ⁇ -propiolactone, ⁇ -butyrolactone, ⁇ -valerolactone, ⁇ -valerolactone, ⁇ -caprolactone, ⁇ , ⁇ -dimethyl- ⁇ -propiolactone, Lactones such as ⁇ -ethyl- ⁇ -valerolactone, ⁇ -methyl-caprolactone, ⁇ -methyl- ⁇ -caprolactone, ⁇ -methyl- ⁇ -caprolactone and enanthlactone; 1,4-dioxane-2,5-dione and Examples thereof include cyclic dimers of hydroxycarboxylic acids such as glycolide and lactide such as 3,6-dimethyl-1,4-dioxane-2,5-dione.
- the cyclic ester compound represented by the general formula (10) is preferably ⁇ -valerolactone, ⁇ -caprolactone, ⁇ -butyrolactone, ⁇ -propiolactone and 1,4-dioxane-2,5-dione. More preferred are ⁇ -valerolactone, ⁇ -propiolactone and ⁇ -caprolactone.
- the amount of the symmetric carbonate compound represented by the general formula (1) used in the present invention can be 0.1 to 100 moles relative to 1 mole of the ester compound represented by the general formula (2). .5 to 70 mol, and in particular, 1 to 50 mol.
- the amount of the symmetrical carbonate compound represented by the general formula (1) is preferably 0.1 to 100 mol with respect to 1 mol of the ester compound represented by the general formula (2a).
- the amount is more preferably 0.5 to 50 mol, particularly preferably 1 to 10 mol.
- the amount of the symmetrical carbonate compound represented by the general formula (1) is preferably 0.1 to 100 with respect to 1 mol of the ester compound represented by the general formula (5a). Mol, more preferably 1 to 70 mol, particularly preferably 5 to 50 mol.
- the amount of the symmetric carbonate compound represented by the general formula (1) is preferably 0.1 to 100 mol with respect to 1 mol of the ester compound represented by the general formula (8a).
- the amount is more preferably 0.5 to 50 mol, particularly preferably 1 to 10 mol.
- the amount of the symmetric carbonate compound represented by the general formula (1) is preferably 0.1 to 100 mol with respect to 1 mol of the cyclic ester compound represented by the general formula (7). More preferably, the amount is 0.3 to 50 mol, particularly preferably 0.5 to 30 mol, and particularly preferably 0.5 to 10 mol.
- hydrolase used in the present invention examples include protease, esterase, lipase, and the like, but preferably from pig liver-derived esterase (PLE), pig liver-derived lipase (PPL), yeast or bacteria.
- Lipids of releasable microorganisms more preferably lipases originating from Burkholderia cepacia (Pseudomonas cepacia) (for example, Amano PS (manufactured by Amano Enzyme), etc.), Candida ann Lipases originating from Candida antarctica (for example, Novozymzy435 (manufactured by Novozyme), etc.), lipases originating from Rhizomucor Miehei (eg, Lipozyme RM IM (manufactured by Novozyme), etc.), Lipase TL, derived from Thermomyces lanuginosus, Mucor Ehei lipase to (Mucor Miehei)
- Hydrolytic enzymes that are commercially available in natural form or as immobilized enzymes can also be used after chemical treatment or physical treatment.
- a hydrolase is dissolved in a buffer solution (an organic solvent may be present if necessary), and this is directly or stirred and then lyophilized.
- a buffer solution an organic solvent may be present if necessary
- freeze-drying means, for example, that an aqueous solution or a substance containing moisture described in J. Am. Chem. Soc., 122 (8), 1565-1571 (2000) is rapidly frozen at a temperature below the freezing point.
- This is a method in which the substance is dried by sublimating the water by subliming the water under the water vapor pressure of the frozen product.
- catalytic treatment reactivity, selectivity, etc.
- the amount of the hydrolase used in the present invention can be 1 to 90% by weight, for example 1 to 70% by weight, based on 1 g of the ester compound represented by the general formula (2). In particular, it can be 1 to 50% by weight.
- the amount of hydrolase is preferably 1 to 50% by weight, more preferably 1 to 30% by weight, when the ester compound represented by the general formula (2a) is 100% by weight. %, Particularly preferably 1 to 10% by weight.
- the amount of hydrolase is preferably 1 to 50% by weight, more preferably 1 to 30% by weight when the ester compound represented by the general formula (5a) is 100% by weight. %, Particularly preferably 1 to 10% by weight.
- the amount of hydrolase is preferably 1 to 110% by weight, more preferably 5 to 70% by weight when the ester compound represented by the general formula (5a) is 100% by weight. %, Particularly preferably 10 to 60% by weight.
- the amount of the hydrolase is preferably 1 to 50% by weight, more preferably 1 to 30% when the ester compound represented by the general formula (8a) is 100% by weight. % By weight, particularly preferably 1 to 10% by weight.
- the amount of hydrolase is preferably 1 to 60% by weight, more preferably 1 to 30% by weight when the ester compound represented by the general formula (7) is 100% by weight. %, Particularly preferably 1 to 25% by weight.
- the reaction of the present invention can be carried out without a solvent or in an organic solvent.
- the organic solvent used in the reaction of the present invention is not particularly limited as long as it does not deactivate the enzyme, but it is desirable to use a dehydrated solvent.
- organic solvent used in the reaction of the present invention examples include aliphatic hydrocarbons such as n-pentane, n-hexane, n-heptane, n-octane, cyclopentane, cyclohexane and cycloheptane; benzene, toluene and Aromatic hydrocarbons such as xylene; ethers such as diethyl ether, t-butyl methyl ether, diisopropyl ether, cyclopentyl methyl ether, tetrahydrofuran and 1,4-dioxane; ketones such as acetone and methyl ethyl ketone; acetonitrile, propionitrile And at least one selected from nitriles such as
- the organic solvent is preferably n-hexane, n-heptane, cyclopentane, cyclohexane, toluene, diisopropyl ether, t-butyl methyl ether, cyclopentyl methyl ether, tetrahydrofuran or acetonitrile, more preferably n-hexane, cyclohexane. , Toluene, diisopropyl ether, t-butyl methyl ether, cyclopentyl methyl ether or acetonitrile, particularly preferably cyclohexane, toluene or t-butyl methyl ether. In addition, you may use these organic solvents individually or in mixture of 2 or more types.
- the amount of the organic solvent used is preferably 200 ml or less, more preferably 0.1 to 50 ml, particularly preferably 0.3 to 30 ml based on 1 g of the symmetrical carbonate compound represented by the general formula (1). Particularly preferred is 0.5 to 15 ml.
- a symmetric carbonate compound represented by the general formula (1), an ester compound represented by the general formula (2), and a hydrolase are mixed and stirred. It is carried out by a method such as reacting while
- the reaction temperature in the reaction of the present invention is preferably 0 to 130 ° C., more preferably 5 to 100 ° C., and particularly preferably 10 to 80 ° C.
- the reaction pressure is not particularly limited, but it is preferably carried out under normal pressure or reduced pressure.
- the reaction of the present invention is a so-called reversible reaction.
- the transesterified compound represented by the general formula (4a) by-produced is a symmetrical carbonate compound represented by the general formula (1) as a raw material and an ester compound represented by the general formula (2a),
- the product may have a low boiling point relative to the asymmetric carbonate compound represented by the general formula (3a). Therefore, by performing the reaction while removing the transesterification compound represented by the general formula (4a) as a by-product to the outside of the reaction system, the reaction proceeds rapidly by moving the chemical equilibrium to the product side.
- An asymmetric carbonate compound represented by the general formula (3a), which is the target product can be obtained efficiently, and is mentioned as one of preferred embodiments of the present invention.
- this method has a boiling point higher than that of the symmetrical carbonate compound represented by the general formula (1) as a raw material, the ester compound represented by the general formula (2a), and the asymmetric carbonate compound represented by the general formula (3a) as a product. It can be achieved by appropriately selecting R 1 , R 2a and R 3a so that a transesterification compound represented by a low general formula (4a) is by-produced.
- reaction formula [II] when R 1 and R 3a are both methyl groups and R 2a is other than a methyl group, it is represented by the general formula (4a) generated by the reaction.
- the transesterification compound (methyl acetate, boiling point: 57-58 ° C.) is expected to have a lower boiling point than the symmetrical carbonate compound represented by the general formula (1) and the ester compound represented by the general formula (2a). .
- the reaction temperature and / or the degree of reduced pressure (0.13 kPa or more and less than 101.3 kPa (1.0 mmHg or more and less than 760 mmHg)), preferably the degree of reduced pressure (above 1.3 kPa and less than 101.3 kPa ( By appropriately adjusting at 10 mmHg or more and less than 760 mmHg, it is possible to produce the ester exchange compound represented by the general formula (4) while selectively removing it from the reaction system. By moving the equilibrium to the production system, this reaction can proceed rapidly, and the target product, the asymmetric carbonate compound represented by the general formula (3a), can be obtained in a shorter reaction time.
- the production apparatus of the present invention is not particularly limited, and can be performed by a general production apparatus such as a reaction vessel or a heating (cooling) apparatus.
- a general production apparatus such as a reaction vessel or a heating (cooling) apparatus.
- a distillation apparatus equipped with a rectifying apparatus a production apparatus provided with a distillate recovery apparatus, More preferably, in addition to the distillation apparatus, the recovery apparatus, etc., use of a production apparatus provided with an apparatus capable of further adjusting the reaction pressure can be mentioned.
- recovery apparatus can also be used for reaction of this invention again.
- the obtained asymmetric carbonate compound can be further purified by general methods such as distillation, liquid separation, extraction, crystallization, recrystallization, column chromatography and the like.
- the asymmetric carbonate compound obtained by the production method of the present invention is produced using a hydrolase, there is a possibility that impurities such as metal salts or halides may be mixed into the product, which may occur in the conventional production method. Is a chemically safer product with extremely low.
- the obtained target product was measured for purity using gas chromatography in addition to IR and NMR spectrum analysis.
- the gas chromatography analysis conditions are as follows.
- Example 1 (Reaction Scheme [II]: Synthesis of n-butylmethyl carbonate)
- Candida antarctica 1.00 g of derived lipase (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 50 ° C. for 63 hours with stirring. After completion of the reaction, the reaction solution was filtered, and the residue was washed with 50 ml of dimethyl carbonate.
- Example 2 Synthesis of n-butylmethyl carbonate
- 1.00 g (8.61 mmol) of n-butyl acetate, 3.63 ml (43.1 mmol) of dimethyl carbonate, and Candida antarctica Lipase 50.7 mg (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 30 ° C. for 33 hours with stirring.
- the obtained reaction solution was filtered, and the residue was washed with 6 ml of dimethyl sulfoxide.
- the obtained filtrate was analyzed by gas chromatography (internal standard method), 0.836 g of n-butylmethyl carbonate was formed (reaction yield based on n-butyl acetate; 73%).
- Example 3 (Scheme [II]: Synthesis of n-butylmethyl carbonate) The same operation as in Example 2 was carried out except that the amount of dimethyl carbonate used was 0.784 g (8.70 mmol) and 3 ml of cyclohexane was added, and the mixture was reacted at 30 ° C. for 24 hours. After completion of the reaction, the obtained reaction solution was filtered to obtain a filtrate. When the obtained filtrate was analyzed by gas chromatography (internal standard method), 0.394 g of n-butylmethyl carbonate was produced (reaction yield based on n-butyl acetate; 35%).
- Example 4 (Scheme [II]: Synthesis of n-butylmethyl carbonate) The same operation as in Example 3 was carried out except that t-butyl methyl ether was used in place of cyclohexane, and the reaction was carried out at 30 ° C. for 24 hours. After completion of the reaction, the obtained reaction solution was filtered. When the obtained filtrate was analyzed by gas chromatography (internal standard method), 0.378 g of n-butylmethyl carbonate was produced (reaction yield; 33%).
- Example 5 (Reaction scheme [II]: Synthesis of ethyl methyl carbonate)
- a glass container with an internal volume of 20 ml equipped with a stirrer and a thermometer 0.504 g (5.72 mmol) of ethyl acetate, 4.78 ml (56.7 mmol) of dimethyl carbonate, and Candida antarctica 25.0 mg of lipase (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 30 ° C. for 80 hours with stirring.
- the obtained reaction solution was analyzed by gas chromatography (internal standard method).
- 0.417 g of ethyl methyl carbonate was formed (reaction yield based on ethyl acetate; 70%).
- Example 6 (Reaction scheme [II]: Synthesis of cyclohexylmethyl carbonate) From a glass container having an internal volume of 20 ml equipped with a stirrer and a thermometer, 1.01 g (7.10 mmol) of cyclohexyl acetate, 2.96 ml (35.1 mmol) of dimethyl carbonate, and Candida antarctica Lipase 50.2 mg (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 30 ° C. for 98 hours with stirring, and 49.7 mg of the same lipase was further added at the same temperature for 98 hours. Thereafter, an additional 49.9 mg was added and reacted for 160 hours.
- Novozym 435 trade name
- Example 7 (Reaction scheme [II]: Synthesis of ethyl methyl carbonate)
- a glass container for a continuous synthesizer 6.47 g (54.7 mmol) of diethyl carbonate, 1.01 g (13.6 mmol) of methyl acetate, and 50.6 mg (Novozym 435) lipase derived from Candida antarctica. (Trade name); manufactured by Novozyme) were mixed and reacted at 40 ° C. for 22 hours with stirring. After completion of the reaction, the obtained reaction solution was filtered to obtain a filtrate. When the obtained filtrate was analyzed by gas chromatography (internal standard method), 0.57 g of ethyl methyl carbonate was produced (reaction yield; 40.2%).
- Comparative Example 1 (Reaction Formula [II]: Synthesis of n-butylmethyl carbonate; no enzyme) While mixing 1.00 g (8.61 mmol) of n-butyl acetate and 3.63 ml (43.1 mmol) of dimethyl carbonate in a glass container having an internal volume of 20 ml equipped with a stirrer, a cooler and a thermometer, while stirring The reaction was performed at 100 ° C. for 24 hours. After completion of the reaction, the obtained reaction solution was filtered, and the obtained filtrate was analyzed by gas chromatography. As a result, n-butylmethyl carbonate was not produced at all.
- Example 8 Synthesis of ethyl methyl carbonate
- a glass container having an internal volume of 10 ml equipped with a stirrer, a thermometer and a condenser tube
- 0.70 g (4.0 mmol) of dimethyl adipate 0.75 g (40.0 mmol) of diethyl carbonate
- Candida antarctica Candida antarctica -derived lipase 0.035 g
- Novozym 435 trade name
- the obtained reaction solution was filtered to obtain a filtrate.
- 0.47 g of ethyl methyl carbonate was produced (reaction yield based on dimethyl adipate; 56.2%).
- Example 9 (Reaction Scheme [IV]: Synthesis of 1,2-dimethoxycarbonyloxyethane)
- ethylene glycol diacetate 1.00 g (6.84 mmol), dimethyl carbonate 28.8 ml (342 mmol), and Candida antarctica (Candida antarctica) -derived lipase (500 mg, Novozym 435 (trade name); manufactured by Novozyme) was mixed and allowed to react at room temperature for 15 hours with stirring. After completion of the reaction, the reaction solution was filtered, and the filtrate was further washed with 5 ml of dimethyl carbonate to obtain a filtrate.
- Example 10 (Reaction Scheme [IV]: Synthesis of 1,2-diethoxycarbonyloxyethane) In a glass container having an internal volume of 50 ml equipped with a stirrer, a thermometer and a condenser tube, 400 mg (2.74 mmol) of ethylene glycol diacetate, 16.6 ml (137 mmol) of diethyl carbonate, and Candida antarctica Origin lipase 200 mg (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at room temperature for 15 hours with stirring.
- Novozym 435 trade name
- Example 11 (Reaction Scheme [IV]: Synthesis of 1,3-dimethoxycarbonyloxypropane)
- dimethyl carbonate 26.0 ml (309 mmol) Dimethyl carbonate 26.0 ml (309 mmol)
- Example 12 (Reaction Scheme [IV]: Synthesis of 1,4-dimethoxycarbonyloxybutane)
- a glass container having an internal volume of 50 ml equipped with a stirrer, a thermometer and a condenser tube
- 1.00 g 5.74 mmol
- 1,4-butanediol diacetate 24.0 ml (285 mmol) of dimethyl carbonate
- Candida Anne 500 mg of lipase derived from Candida antarctica Novozym 435 (trade name); manufactured by Novozyme
- Example 13 (Reaction Scheme [IV]: Synthesis of 1,6-dimethoxycarbonyloxyhexane)
- a glass container having an internal volume of 50 ml equipped with a stirrer, a thermometer and a condenser tube
- 1.00 g (4.94 mmol) of 1,6-hexanediol diacetate 1.00 ml (249 mmol) of dimethyl carbonate
- Candida Anne 500 mg of lipase derived from Candida antarctica Novozym 435 (trade name); manufactured by Novozyme
- Example 14 (Reaction Scheme [IV]: Synthesis of 1,4-dimethoxycarbonyloxy-cis-2-butene)
- cis-2-butene-1,4-diol diacetate 5.14 g (30 mmol), dimethyl carbonate 26.00 g (288 mmol), and Candida antarctica ( Candida antarctica) -derived lipase 0.5 g (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 70 ° C. for 69 hours with stirring, and further added with 2 g of dimethyl carbonate and stirred at 70 ° C. for 7 hours.
- Example 15 (Reaction Scheme [IV]: Synthesis of 1-methoxycarbonyloxy-2- (methoxycarbonyloxyethoxy) ethane)
- the reaction solution was concentrated in the presence of the enzyme, and 38.85 g of dimethyl carbonate was added to the mixture at 70 ° C. for 24 hours. Stir.
- reaction solution was concentrated in the presence of an enzyme, 30.1 g of dimethyl carbonate was added, and the mixture was stirred at 70 ° C. for 24 hours. After completion of the reaction, the reaction solution was filtered while washing with dimethyl carbonate to obtain a filtrate. The obtained filtrate was concentrated, and a part (3.79 g) was purified by Kugelrohr distillation to confirm the amount of the product. As a result, 14.66 g of 1-methoxycarbonyloxy-2- (Methoxycarbonyloxyethoxy) ethane was included (isolated yield based on diethylene glycol diacetate; 53%).
- Example 16 (Reaction Scheme [IV]: Synthesis of 1,12-dimethoxycarbonyloxide decane) From a glass container with an internal volume of 200 ml equipped with a stirrer, derived from 20.12 g (71 mmol) of 1,12-dodecanediol diacetate, 31.35 g (348 mmol) of dimethyl carbonate, and Candida antarctica 3.77 g of lipase (Novozym 435 (trade name); manufactured by Novozyme) was mixed, reacted at 70 ° C. for 48 hours with stirring, the reaction solution was concentrated in the presence of the enzyme, and 30.24 g of dimethyl carbonate was added. The mixture was stirred at 70 ° C. for 24 hours.
- Example 17 (Reaction scheme [VI]: Synthesis of methyl 6-methoxycarbonyloxyhexanoate) Derived from 1.01 g (8.85 mmol) of ⁇ -caprolactone, 3.94 g (43.7 mmol) of dimethyl carbonate and Candida antarctica in a 20 ml glass container equipped with a stirrer and a thermometer Lipase 51.1 mg (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 30 ° C. for 186 hours with stirring. After completion of the reaction, the obtained reaction solution was filtered, and the residue was washed with 30 ml of dimethyl carbonate to obtain a filtrate.
- Reaction scheme [VI] Synthesis of methyl 6-methoxycarbonyloxyhexanoate
- Example 18 (Reaction scheme [VI]: Synthesis of methyl 6-methoxycarbonyloxyhexanoate)
- a glass container having an internal volume of 500 ml equipped with a stirrer, a thermometer and a reflux condenser
- 22.8 g (0.200 mol) of ⁇ -caprolactone 22.8 g (0.200 mol) of ⁇ -caprolactone
- Candida antarctica 2.28 g of lipase derived from Candida antarctica
- Novozym 435 trade name
- the reaction was carried out at the same temperature for 7 hours.
- Example 19 (Reaction scheme [VI]: Synthesis of methyl 6-methoxycarbonyloxyhexanoate)
- a 500 ml glass container equipped with a stirrer, thermometer and reflux condenser 45.6 g (0.400 mol) of ⁇ -caprolactone, 180 g (2.00 mol) of dimethyl carbonate and Candida antarctica (Candida antarctica) ) -Derived lipase 9.12 g (Novozym 435 (trade name); manufactured by Novozyme) was mixed and reacted at 80 ° C. for 23 hours with stirring.
- Example 20 (Reaction scheme [VI]: Synthesis of methyl 6-methoxycarbonyloxyhexanoate) The same operation as in Example 19 was carried out except that the amount of dimethyl carbonate used was 360 g (4.00 mol), and the mixture was reacted at 80 ° C. for 48 hours. After completion of the reaction, the resulting reaction solution was cooled to room temperature and then filtered. When the obtained filtrate was quantitatively analyzed by gas chromatography (internal standard method), 71.3 g of methyl 6-methoxycarbonyloxyhexanoate was formed (reaction yield based on ⁇ -caprolactone; 87%).
- Example 21 (Scheme [VI]: methyl 5-methoxycarbonyloxypentanoate)
- a glass container having an internal volume of 200 ml equipped with a stirrer, a thermometer and a reflux condenser
- 25.0 g (0.25 mol) of ⁇ -valerolactone 112.5 g (1.25 mol) of dimethyl carbonate
- Candida antarctica Candida antarctica
- -derived lipase 5.00 g Novozym 435 (trade name); manufactured by Novozyme
- the obtained filtrate was concentrated under reduced pressure to obtain 52.3 g of a concentrated solution.
- this concentrated solution was quantified by an internal standard method by gas chromatography, 36.6 g of methyl 5-methoxycarbonyloxypentanoate was formed (reaction yield based on ⁇ -valerolactone; 77.0%).
- this concentrated liquid was purified by distillation under reduced pressure, 27.0 g of methyl 5-methoxycarbonyloxypentanoate was obtained as a colorless liquid (106 to 107 ° C./0.9 to 1.1 kPa) (purity (gas chromatography Area percentage); 98.8%, isolated yield based on ⁇ -valerolactone; 56.1%).
- Example 22 (Scheme [VI]: methyl 3-methoxycarbonyloxypropionate)
- a glass container having an internal volume of 300 ml equipped with a stirrer, a thermometer and a reflux condenser
- 28.6 g (0.38 mol) of ⁇ -propiolactone having a purity of 95%
- 178.7 g (1.98 mol) of dimethyl carbonate and
- a lipase derived from Candida antarctica (5.72 g) (Novozym 435 (trade name); manufactured by Novozyme) was mixed and allowed to react at 60 ° C. for 14.5 hours.
- this concentrated liquid was purified by distillation under reduced pressure to obtain 32.6 g of methyl 3-methoxycarbonyloxypropionate as a colorless liquid (81 to 83 ° C./0.7 to 0.8 kPa) (purity (gas Chromatographic area percentage); 97.3%, isolated yield based on ⁇ -propiolactone; 51.5%).
- Example 23 (Scheme [III]: 4-methoxycarbonyloxybutyl acetate)
- a glass container having an internal volume of 200 ml equipped with a stirrer, a thermometer and a reflux condenser
- 174.2 g (1.00 mol) of 1,4-butanediol diacetate 180.0 g (2.00 mol) of dimethyl carbonate
- Candida -8.70 g of lipase derived from Candida antarctica Novozym 435 (trade name); manufactured by Novozyme
- the obtained filtrate was concentrated under reduced pressure to obtain 196.0 g of a concentrated solution.
- This concentrated liquid was purified by distillation under reduced pressure, 10.6 g of 4-methoxycarbonyloxybutyl acetate was obtained as a colorless liquid (99 to 103 ° C./0.6 to 0.8 kPa) (purity: (gas chromatography Area percentage); 79.2%).
- the physical properties of the obtained 4-methoxycarbonyloxybutyl acetate were as follows.
- the present invention relates to a method for obtaining an asymmetric carbonate compound from a carbonate compound and an ester compound.
- the asymmetric carbonate compound obtained by the present invention is a useful compound as a solvent, various organic synthesis reagents, a fragrance, and a functional material.
- it is useful as an electrolyte or a solvent for a rechargeable alkaline electrochemical battery such as a lithium secondary battery.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
で示される対称カーボネート化合物と、一般式(2):
R2及びR3は、それぞれ独立して、置換基を有していてもよい1価の炭化水素基(ここで、R2及びR3における炭化水素基は、エーテル結合、チオエーテル結合、アミド結合、カルボニル結合及びエステル結合からなる群より選択される結合基により中断されていてもよい)であるか、あるいは
R2及びR3は、互いに結合してZであり、Zは、置換基を有していてもよい2価の炭化水素基(ここで、Zにおける炭化水素基は、エーテル結合、チオエーテル結合、アミド結合、カルボニル結合及びエステル結合からなる群より選択される結合基により中断されていてもよい)であるが、
ただし、R2は、一般式(1)のR1と同一ではなく、かつ一般式(2a)に含まれるエステル結合は全部で2個以下とする〕
で示されるエステル化合物とを反応させて、一般式(3):
R1は、前記で定義されたとおりであり、
R2’は、R2であるが、
ただし、R2及びR3が、互いに結合してZである場合、R2’は、-Z-C(=O)-O-R1である))
で示される非対称カーボネート化合物を得ることを特徴とする、非対称カーボネート化合物の製造方法に関する。
で示される対称カーボネート化合物と、一般式(2a):
R2a及びR3aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基(ここで、R2a及びR3aにおける炭化水素基は、エーテル結合、チオエーテル結合、アミド結合、カルボニル結合及びエステル結合からなる群より選択される結合基により中断されていてもよい)であるが、
ただし、R2aは、一般式(1)のR1と同一ではなく、かつ一般式(2)に含まれるエステル結合は全部で2個以下とする〕
で示されるエステル化合物とを反応させて、一般式(3a):
で示される非対称カーボネート化合物を得る、本発明1の非対称カーボネート化合物の製造方法に関する。
で示されるエステル交換化合物を除去しながら行なう、本発明2の非対称カーボネート化合物の製造方法に関する。
で示される対称カーボネート化合物と、一般式(5a):
R4a及びR5aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基であり、
Xは、置換基を有していてもよい2価の炭化水素基(ここで、炭化水素基は、エーテル結合、チオエーテル結合、アミド結合及びカルボニル結合からなる群より選択される結合基により中断されていてもよい)である〕
で示されるエステル化合物とを反応させて、一般式(6a):
R6は、R4a又はR5aであり、
R1、X、R4a及びR5aは、前記のとおりである)
で示される非対称カーボネート化合物を得る、本発明1の非対称カーボネート化合物の製造方法に関する。
Xが、炭素数1~6のアルキレン基又は炭素数1~6のアルケニレン基、又はエーテル結合により中断されている炭素原子数2~6の直鎖状アルキレン基である、本発明8の非対称カーボネート化合物の製造方法に関する。
で示される対称カーボネート化合物と、一般式(5a):
R4a及びR5aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基であり、
Xは、置換基を有していてもよい2価の炭化水素基(ここで、炭化水素基は、エーテル結合、チオエーテル結合、アミド結合及びカルボニル結合からなる群より選択される結合基により中断されていてもよい)である〕
で示されるエステル化合物とを反応させて、一般式(7a):
で示される非対称カーボネート化合物を得る、本発明1の非対称カーボネート化合物の製造方法に関する。
で示される対称カーボネート化合物と、一般式(8a):
R7a及びR8aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基であり、
Yは、置換基を有していてもよい2価の炭化水素基(ここで、炭化水素基は、エーテル結合、チオエーテル結合、アミド結合及びカルボニル結合からなる群より選択される結合基により中断されていてもよい)である〕
で示されるエステル化合物とを反応させて、一般式(9a):
R10aは、R7a又はR8aであり、
R1、R7a及びR8aは、前記のとおりである)
で示される非対称カーボネート化合物を得る、本発明1の非対称カーボネート化合物の製造方法に関する。
で示される対称カーボネート化合物と、一般式(10):
で示される環状のエステル化合物とを反応させて、一般式(11):
で示される非対称カーボネート化合物を得る、本発明1の非対称カーボネート化合物の製造方法に関する。
R1、Xは、R4a及びR5aは、前記で定義されたとおりである)
で示される非対称カーボネート化合物に関する。
R1、R7a及びR8aは、前記で定義されたとおりである)
で示される非対称カーボネート化合物に関する。
本発明においては、加水分解酵素の存在下、一般式(1)で示されるカーボネート化合物と一般式(2)で示されるエステル化合物との反応により、一般式(3)で示される非対称カーボネート化合物が生成する(反応式〔I〕)。
一般式(2)のエステル化合物は、一般式(2a)のエステル化合物を包含する。加水分解酵素の存在下、一般式(1)で示されるカーボネート化合物と一般式(2a)で示されるエステル化合物との反応により、一般式(3a)で示される非対称カーボネート化合物及び一般式(4a)で示されるエステル交換化合物が生成する(反応式〔II〕)。
一般式(2)は、一般式(5a)を包含する。加水分解酵素の存在下、一般式(1)で示されるカーボネート化合物と一般式(5a)で示されるエステル化合物との反応により、一般式(6a)で示される非対称カーボネート化合物が生成する(反応式〔III〕)。
エーテル結合により中断されている、炭素原子数2~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基、あるいはエーテル結合で中断されている、フェニレン基、ナフチレン基又はビフェニレン基及び炭素原子数1~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基からなる炭化水素基(例えば、アルキレン-O-アリーレン(例えば、C1~C6アルキレン-O-フェニレン));
チオエーテル結合により中断されている、炭素原子数2~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基、あるいはチオエーテル結合で中断されている、フェニレン基、ナフチレン基又はビフェニレン基及び炭素原子数1~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基からなる炭化水素基(例えば、アルキレン-S-アリーレン(例えば、C1~C6アルキレン-S-フェニレン));
アミド結合により中断されている、炭素原子数2~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基、あるいはアミド結合で中断されている、フェニレン基、ナフチレン基又はビフェニレン基及び炭素原子数1~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基からなる炭化水素基(例えば、アルキレン-CONH-アリーレン、アリーレン-CONH-C1~C6アルキレン(例えば、C1~C6アルキレン-CONH-フェニレン、フェニレン-CONH-C1~C6アルキレン));
カルボニル結合により中断されている、炭素原子数2~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基、あるいはカルボニル結合で中断されている、フェニレン基、ナフチレン基又はビフェニレン基及び炭素原子数1~6の直鎖状アルキレン基又は炭素原子数3~6の分岐鎖状アルキレン基からなる炭化水素基(例えば、アルキレン-CO-アリーレン、アリーレン-CO-アルキレン(例えば、C1~C6アルキレン-CO-フェニレン、フェニレン-CO-C1~C6アルキレン))が挙げられる。なお、これらの基は各種異性体を含む。
加水分解酵素の存在下、一般式(1)で示されるカーボネート化合物と一般式(5a)で示されるエステル化合物との反応により、一般式(7a)で示される非対称カーボネート化合物が生成する(反応式〔IV〕)。
一般式(2)の化合物は、一般式(8a)の化合物を包含する。加水分解酵素の存在下、一般式(1)で示されるカーボネート化合物と一般式(8a)で示されるエステル化合物との反応により、一般式(9a)で示される非対称カーボネート化合物及び一般式(12a)で示されるエステル交換化合物が生成する(反応式〔V〕)。
一般式(2)の化合物は、一般式(10)の化合物を包含する。加水分解酵素の存在下、一般式(1)で示されるカーボネート化合物と一般式(10)で示される環状エステル化合物との反応により、一般式(11)で示される非対称カーボネート化合物が生成する(反応式〔VI〕)。
また、回収装置により、回収された蒸留物のうち、一般式(4a)で示されるエステル交換化合物、及び未反応原料化合物は、再度本発明の反応に使用することもできる。
るものではない。
分析装置:GC-17A(SHIMADZU製)
使用カラム:DB-WAX(J&W製);0.53mmI.D.*30m,膜厚1μm
分析温度:開始温度:40℃(10分間保持)、終了温度230℃(31分間保持)
昇温速度:10℃/min
キャリアガス:ヘリウム,11.13ml/min
注入口:スプリットなし,230℃
検出器:FID,230℃
攪拌装置、温度計及び冷却管を備えた内容積100mlのガラス製容器に、酢酸n-ブチル20.0g(172mmol)、炭酸ジメチル72.5ml(860mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ1.00g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら50℃にて63時間反応させた。反応終了後、反応液を濾過し、濾物を炭酸ジメチル50mlを用いて洗浄した。濾液を濃縮した後、減圧蒸留にて精製し、無色液体として炭酸n-ブチルメチル7.45gを得た(純度(ガスクロマトグラフィーによる面積百分率);96.8%、酢酸n-ブチル基準の単離収率;33%)。
CI-MS(m/z);133[M+1]。
1H-NMR(CDCl3,δ(ppm));0.94(3H,t,J=7.32Hz)、1.40(2H,tq,J=7.32,Hz)、1.66(2H,tt,J=6.59,Hz)、3.78(3H,s)、4.14(2H,t,J=6.59Hz)。
13C-NMR(CDCl3,δ(ppm));13.7、18.9、30.7、54.6、68.0、155.9。
EA;Calcd:C,54.53%;H,9.15%;O,36.32%
Found:C,53.69%;H,8.96%。
攪拌装置及び温度計を備えた内容積20mlのガラス製容器に、酢酸n-ブチル1.00g(8.61mmol)、炭酸ジメチル3.63ml(43.1mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ50.7mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら30℃で33時間反応させた。反応終了後、得られた反応液を濾過し、濾物をジメチルスルホキシド6mlを用いて洗浄した。得られた濾液をガスクロマトグラフィーにて分析(内部標準法)したところ、炭酸n-ブチルメチル0.836gが生成していた(酢酸n-ブチル基準の反応収率;73%)。
炭酸ジメチルの使用量を0.784g(8.70mmol)とし、シクロヘキサン3mlを加えた以外、実施例2と同様の操作を行い、30℃にて24時間反応させた。反応終了後、得られた反応液を濾過し、濾液を取得した。得られた濾液をガスクロマトグラフィーにて分析(内部標準法)したところ、炭酸n-ブチルメチル0.394gが生成していた(酢酸n-ブチル基準の反応収率;35%)。
シクロヘキサンの代わりにt-ブチルメチルエーテルを用いた以外、実施例3と同様の操作を行い、30℃で24時間反応させた。反応終了後、得られた反応液を濾過した。得られた濾液をガスクロマトグラフィーにて分析(内部標準法)したところ、炭酸n-ブチルメチル0.378gが生成していた(反応収率;33%)。
攪拌装置及び温度計を備えた内容積20mlのガラス製容器に、酢酸エチル0.504g(5.72mmol)、炭酸ジメチル4.78ml(56.7mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ25.0mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら30℃にて80時間反応させた。反応終了後、得られた反応液をガスクロマトグラフィーにて分析(内部標準法)したところ、炭酸エチルメチル0.417gが生成していた(酢酸エチル基準の反応収率;70%)。
攪拌装置及び温度計を備えた内容積20mlのガラス製容器に、酢酸シクロヘキシル1.01g(7.10mmol)、炭酸ジメチル2.96ml(35.1mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ50.2mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら30℃にて98時間反応させ、更に同温度にて同リパーゼ49.7mgを追加して98時間、その後、更に49.9mgを追加して160時間反応させた。反応終了後、得られた反応液を濾過し、濾物をt-ブチルメチルエーテル40mlを用いて洗浄した。得られた濾液を飽和食塩水5mlを用いて2回洗浄した後、有機層を抽出し、無水硫酸マグネシウムを用いて乾燥した。得られた有機層を濃縮したところ、無色液体として炭酸シクロヘキシルメチル0.686gを得た(純度(ガスクロマトグラフィーによる面積百分率);85.6%、酢酸シクロヘキシル基準の単離収率;52%)。
CI-MS(m/z);159[M+1]。
1H-NMR(CDCl3,δ(ppm));1.18-1.59(6H,m)、1.70-1.80(2H,m)、1.87-1.97(2H,m)、3.77(3H,s)、4.62(1H,tt,J=3.91,9.16Hz)。
13C-NMR(CDCl3,δ(ppm));23.6、25.3、31.6、54.4、76.8、155.3。
IR(液膜法、cm-1);793、951、1013、1035、1259、1277、1320、1444、1746、2861、2940。
連続合成装置用ガラス製容器に、炭酸ジエチル6.47g(54.7mmol)、酢酸メチル1.01g(13.6mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ50.6mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら40℃にて22時間反応させた。反応終了後、得られた反応液を濾過し、濾液を取得した。得られた濾液をガスクロマトグラフィーにて分析(内部標準法)したところ、炭酸エチルメチル0.57gが生成していた(反応収率;40.2%)。
攪拌装置、冷却器及び温度計を備えた内容積20mlのガラス製容器に、酢酸n-ブチル1.00g(8.61mmol)及び炭酸ジメチル3.63ml(43.1mmol)を混合し、攪拌しながら100℃にて24時間反応させた。反応終了後、得られた反応液を濾過し、得られた濾液をガスクロマトグラフィーにて分析したところ、炭酸n-ブチルメチルは全く生成していなかった。
攪拌装置、温度計及び冷却管を備えた内容積10mlのガラス製容器に、アジピン酸ジメチル0.70g(4.0mmol)、炭酸ジエチル4.75g(40.0mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ0.035g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら40℃にて24時間反応させた。反応終了後、得られた反応液を濾過し、濾液を取得した。得られた濾液をガスクロマトグラフィーにて分析(内部標準法)したところ、炭酸エチルメチル0.47gが生成していた(アジピン酸ジメチル基準の反応収率;56.2%)。
攪拌装置、温度計及び冷却管を備えた内容積50mlのガラス製容器に、エチレングリコールジアセテート1.00g(6.84mmol)、炭酸ジメチル28.8ml(342mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ500mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら室温にて15時間反応させた。反応終了後、反応液を濾過し、更に濾物は炭酸ジメチル5mlを用いて洗浄し、濾液を得た。得られた濾液を濃縮したところ、無色液体として1,2-ジメトキシカルボニルオキシエタン1.10gを得た(純度(ガスクロマトグラフィーによる面積百分率);84.4%、エチレングリコールジアセテート基準の単離収率;76%)。
CI-MS(m/z);179[M+1]。
1H-NMR(CDCl3,δ(ppm));3.80(6H,s)、4.37(4H,s)。
13C-NMR(CDCl3,δ(ppm));55.0、18.65.4.155.6。
IR(液膜法、cm-1);791、866、947、1032、1254、1299、1346、1376、1405、1445、1754、2963、3008。
EA;Calcd:C,40.45%;H,5.66%
Found:C,40.64%;H,5.40%。
攪拌装置、温度計及び冷却管を備えた内容積50mlのガラス製容器に、エチレングリコールジアセテート400mg(2.74mmol)、炭酸ジエチル16.6ml(137mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ200mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら室温にて15時間反応させた。更にカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ200mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら室温にて24時間反応させた。
反応終了後、反応液を濾過し、濾物はアセトニトリル5mlを用いて洗浄し、濾液を得た。得られた濾液を濃縮したところ、無色液体として1,2-ジエトキシカルボニルオキシエタン522mgを得た(純度(ガスクロマトグラフィーによる面積百分率);86.5%、エチレングリコールジアセテート基準の単離収率;80%)。
CI-MS(m/z);207[M+1]。
1H-NMR(CDCl3,δ(ppm));1.31(4H,t,J=7.08Hz)、4.21(6H,q,J=7.08Hz)、4.36(4H,s)。
13C-NMR(CDCl3,δ(ppm));64.3、65.2、154.9。
IR(液膜法、cm-1);474、790、858、882、1008、1033、1092、1115、1177、1243、1287、1341、1380、1402、1448、1583、1749、2914、2987。
EA;Calcd:C,46.60%;H,6.84%
Found:C,46.93%;H,6.70%。
攪拌装置、温度計及び冷却管を備えた内容積50mlのガラス製容器に、1,3-プロパンジオールジアセテート1.00g(6.24mmol)、炭酸ジメチル26.0ml(309mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ500mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら室温にて48時間反応させた。反応終了後、反応液を濾過し、濾物は炭酸ジメチル5mlを用いて洗浄し、濾液を得た。得られた濾液を濃縮したところ、無色液体として1,3-ジメトキシカルボニルオキシプロパン1.13gを得た(純度(ガスクロマトグラフィーによる面積百分率);87.7%、1,3-プロパンジオールジアセテート基準の単離収率;83%)。
CI-MS(m/z);193[M+1]。
1H-NMR(CDCl3,δ(ppm));2.05(2H,tt,J=6.35、6.35Hz)、3.79(6H,s)、4.29(4H,t,J=6.35Hz)。
13C-NMR(CDCl3,δ(ppm));28.2、54.8、64.3、155.7。
IR(液膜法、cm-1);457、793、907、941、976、1028、1114、1259、1332、1363、1389、1445、1750、2911、2963。
EA;Calcd:C,43.75%;H,6.29%
Found:C,44.20%;H,6.17%。
攪拌装置、温度計及び冷却管を備えた内容積50mlのガラス製容器に、1,4-ブタンジオールジアセテート1.00g(5.74mmol)、炭酸ジメチル24.0ml(285mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ500mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら室温にて48時間反応させた。反応終了後、反応液を濾過し、濾物はアセトニトリル5mlを用いて洗浄し、濾液を得た。得られた濾液を濃縮したところ、白色固体として1,4-ジメトキシカルボニルオキシブタン1.12gを得た(純度(ガスクロマトグラフィーによる面積百分率);94.3%、1,4-ブタンジオールジアセテート基準の単離収率;89%)。
CI-MS(m/z);207[M+1]。
1H-NMR(CDCl3,δ(ppm));1.78(4H,m)、3.78(6H,s)、4.18(4H,m)。
13C-NMR(CDCl3,δ(ppm));25.2、54.7、67.4、155.8。
IR(KBr法、cm-1);558、721、743、795、934、959、1055、1111、1249、1292、1405、1446、1484、1753、2864、2886、2910、2983、3022、3467。
EA;Calcd:C,46.60%;H,6.84%
Found:C,47.13%;H,6.70%。
攪拌装置、温度計及び冷却管を備えた内容積50mlのガラス製容器に、1,6-ヘキサンジオールジアセテート1.00g(4.94mmol)、炭酸ジメチル21.0ml(249mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ500mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら室温にて48時間反応させた。反応終了後、反応液を濾過し、濾物はアセトニトリル5mlを用いて洗浄し、濾液を得た。得られた濾液を濃縮したところ、白色固体として1,6-ジメトキシカルボニルオキシヘキサン1.09gを得た(純度(ガスクロマトグラフィーによる面積百分率);91.1%、1,6-ヘキサンジオールジアセテート基準の単離収率;86%)。
CI-MS(m/z);235[M+1]。
1H-NMR(CDCl3,δ(ppm));1.42(4H,m)、1.68(4H,m)、3.77(6H,s)、4.14(4H,t,J=6.59Hz)。
13C-NMR(CDCl3,δ(ppm));25.4、28.6、54.6、68.0、155.9。
IR(KBr法、cm-1);422、572、721、791、803、932、957、1027、1076、1112、1291、1348、1403、1445、1485、1702、1755、2875、2924、2943、2969、3020、3467。
EA;Calcd:C,51.27%;H,7.75%
Found:C,51.23%;H,7.56%。
攪拌装置を備えた内容積200mlのガラス製容器に、シス-2-ブテン-1,4-ジオールジアセテート5.14g(30mmol)、炭酸ジメチル26.00g(288mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ0.5g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら70℃で69時間反応させ、更に炭酸ジメチル2gを追加して70℃で7時間攪拌した後、減圧(750hPa)条件下、70℃で5時間反応した。反応終了後、反応液を炭酸ジメチルで洗浄しながらろ過し、濾液を得た。得られた濾液を濃縮し、一部(3.08g)をクーゲルロール蒸留(kugelrohr distillation)にて精製し生成物量を確認したところ、全濾液中に2.54gの1,4-ジメトキシカルボニルオキシ-シス-2-ブテンが含まれていた(シス-2-ブテン-1,4-ジオールジアセテート基準の収率;42%)。
CI-MS(m/z);129〔M-OC(O)OMe〕
1H-NMR(CDCl3,δ(ppm));5.81(2H,m,J=1.22Hz)、4.74-4.76(4H,dd,J=1.46,4.15Hz)、3.79(6H,s)。
攪拌装置を備えた内容積200mlのガラス製容器に、ジエチレングリコールジアセテート25.27g(132mmol)、炭酸ジメチル59.2g(657mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ7.56g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら70℃で68時間反応させ、酵素存在下で反応液を濃縮し、炭酸ジメチル38.85gを追加して70℃で24時間攪拌した。攪拌後、酵素存在下で反応液を濃縮し、炭酸ジメチル30.1gを追加して70℃で24時間攪拌した。反応終了後、反応液を炭酸ジメチルで洗浄しながらろ過し、濾液を得た。得られた濾液を濃縮し、一部(3.79g)をクーゲルロール蒸留(kugelrohr distillation)にて精製し生成物量を確認したところ、全濾液中に14.66gの1-メトキシカルボニルオキシ-2-(メトキシカルボニルオキシエトキシ)エタンが含まれていた(ジエチレングリコールジアセテート基準の単離収率;53%)。
CI-MS(m/z);223〔M+1〕
1H-NMR(CDCl3,δ(ppm));4.27-4.30(4H,t,J=4.63Hz)、3.79(6H,s)、3.71-3.74(4H,t,J=4.63Hz)。
攪拌装置を備えた内容積200mlのガラス製容器に、1,12-ドデカンジオールジアセテート20.42g(71mmol)、炭酸ジメチル31.35g(348mmol)、及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ3.77g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら70℃で48時間反応させ、酵素存在下で反応液を濃縮し、炭酸ジメチル30.24gを追加して70℃で24時間攪拌した。攪拌後、酵素存在下で反応液を濃縮し、炭酸ジメチル30.22gを追加して70℃で25時間攪拌し、酵素存在下で反応液を濃縮し、炭酸ジメチル30.23gを追加して70℃で20時間攪拌した。反応終了後、反応液を炭酸ジメチルとテトラヒドロフランで洗浄しながらろ過し、濾液を得た。得られた濾液を濃縮し、一部(1.17g)をクーゲルロール蒸留(kugelrohr distillation)にて精製し生成物量を確認したところ、全濾液中に14.38gの1,12-ジメトキシカルボニルオキシドデカンが含まれていた(1,12-ドデカンジオールジアセテート基準の収率;63%)。
CI-MS(m/z);319〔M+1〕
1H-NMR(CDCl3,δ(ppm));4.10-4.15(4H,t,J=6.83Hz)、3.77(6H,s)、1.61-1.70(4H,m,J=6.59Hz)、1.26-1.38(16H,m)。
攪拌装置及び温度計を備えた内容積20mlのガラス製容器に、ε-カプロラクトン1.01g(8.85mmol)、炭酸ジメチル3.94g(43.7mmol)及びカ
ンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ51.1mg(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら30℃にて186時間反応させた。反応終了後、得られた反応液を濾過し、濾物は炭酸ジメチル30mlを用いて洗浄し、濾液を得た。得られた濾液を濃縮したところ、無色液体として6-メトキシカルボニルオキシヘキサン酸メチル1.68gを得た(純度ガスクロマトグラフィーによる面積百分率);84.0%、ε-カプロラクトン基準の単離収率;78%)。
CI-MS(m/z);205[M+1]。
1H-NMR(CDCl3,δ(ppm));1.35~1.47(2H,m)、1.61~1.74(4H,m)、2.33(2H,t,J=7.45Hz)、3.67(3H,s)、3.78(3H,s)、4.14(2H,t,J=6.59Hz).
13C-NMR(CDCl3,δ(ppm));24.5、25.3、28.4、33.9、51.5、54.7、67.9、155.9、173.9
IR(液膜法、cm-1);794、957、1013、1103、1168、1200、1269、1363、1388、1443、1747、2866、2956.
攪拌装置、温度計及び還流冷却器を備えた内容積500mlのガラス製容器に、ε-カ
プロラクトン22.8g(0.200mol)、炭酸ジメチル90.1g(1.00mol)及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ2.28g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら60℃にて31時間反応させ、更に炭酸ジメチル45.1g(0.501mol)を加えて、同温度下、7時間反応させた。反応終了後、得られた反応液を室温まで冷却し、その後濾過した。得られた濾液を減圧蒸留にて精製したところ、無色液体(138~139℃/1.6~1.7kPa)として、6-メトキシカルボニルオキシヘキサン酸メチル17.8gを得た(純度(ガスクロマトグラフィーによる面積百分率);98.0%、ε-カプロラクトン基準の単離収率;43%)。
攪拌装置、温度計及び還流冷却器を備えた内容積500mlのガラス製容器に、ε-カプロラクトン45.6g(0.400mol)、炭酸ジメチル180g(2.00mol)及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ9.12g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら80℃にて23時間反応させた。反応終了後、得られた反応液を室温まで冷却し、炭酸ジメチル90.1g(1.00mol)を加えて濾過した。得られた濾液をガスクロマトグラフィーにて定量分析(内部標準法)したところ、6-メトキシカルボニルオキシヘキサン酸メチル66.9gが生成していた(ε-カプロラクトン基準の反応収率;82%)。
炭酸ジメチルの使用量を360g(4.00mol)とした以外、実施例19と同様の操作を行い、80℃にて48時間反応させた。反応終了後、得られた反応液を室温まで冷却し、その後濾過した。得られた濾液をガスクロマトグラフィーにて定量分析(内部標準法)したところ、6-メトキシカルボニルオキシヘキサン酸メチル71.3gが生成していた(ε-カプロラクトン基準の反応収率;87%)。
攪拌装置、温度計及び還流冷却器を備えた内容積200mlのガラス製容器に、δ-バレロラクトン25.0g(0.25mol)、炭酸ジメチル112.5g(1.25mol)及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ5.00g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら60℃にて35時間反応させた。反応終了後、得られた反応液を室温まで冷却し、その後濾過した。得られた濾液を減圧濃縮し、濃縮液52.3gを得た。この濃縮液をガスクロマトグラフィーによる内部標準法にて定量したところ、5-メトキシカルボニルオキシペンタン酸メチルが36.6g生成していた(δ-バレロラクトン基準の反応収率;77.0%)。この濃縮液を減圧蒸留にて精製したところ、無色液体(106~107℃/0.9~1.1kPa)として、5-メトキシカルボニルオキシペンタン酸メチル27.0gを得た(純度(ガスクロマトグラフィーによる面積百分率);98.8%、δ-バレロラクトン基準の単離収率;56.1%)。
CI-MS(m/z);191[M+1]
1H-NMR(CDCl3,δ(ppm));1.70~1.75(4H,m)、2.34~2.39(2H,m)、3.67(3H,s)、3.78(3H,s)、4.13~4.18(2H,m).
攪拌装置、温度計及び還流冷却器を備えた内容積300mlのガラス製容器に、純度95%のβ-プロピオラクトン28.6g(0.38mol)、炭酸ジメチル178.7g(1.98mol)及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ5.72g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら60℃にて14.5時間反応させた。その後、更にカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ5.72g(Novozym 435(商品名);ノボザイム社製)を添加し、60℃にて40時間反応させた。反応終了後、得られた反応液を室温まで冷却し、その後濾過した。得られた濾液を減圧濃縮し、濃縮液70.5gを得た。この濃縮液をガスクロマトグラフィーにて定量(内部標準法)したところ、3-メトキシカルボニルオキシプロピオン酸メチルが42.8g生成していた(β-プロピオラクトン基準の反応収率;69.5%)。
次いで、この濃縮液を減圧蒸留にて精製したところ、無色液体(81~83℃/0.7~0.8kPa)として、3-メトキシカルボニルオキシプロピオン酸メチル32.6gを得た(純度(ガスクロマトグラフィーによる面積百分率);97.3%、β-プロピオラクトン基準の単離収率;51.5%)。
CI-MS(m/z);163[M+1]
1H-NMR(CDCl3,δ(ppm));2.68~2.73(2H,t,J=6.35Hz)、3.71(3H,s)、3.79(3H,s)、4.36~4.44(2H,t,J=6.35Hz).
攪拌装置、温度計及び還流冷却器を備えた内容積200mlのガラス製容器に、1,4-ブタンジオールジアセテート174.2g(1.00mol)、炭酸ジメチル180.0g(2.00mol)及びカンジダ・アンタークティカ(Candida antarctica)由来のリパーゼ8.70g(Novozym 435(商品名);ノボザイム社製)を混合し、攪拌しながら70℃にて32時間反応させた。反応終了後、得られた反応液を室温まで冷却し、その後濾過した。得られた濾液を減圧濃縮し、濃縮液196.0gを得た。この濃縮液を減圧蒸留にて精製したところ、無色液体(99~103℃/0.6~0.8kPa)として、4-メトキシカルボニルオキシブチルアセテート10.6gを得た(純度:(ガスクロマトグラフィーによる面積百分率);79.2%)。
得られた4-メトキシカルボニルオキシブチルアセテートの物性値は、以下の通りであった。
CI-MS(m/z);191[M+1]
1H-NMR(CDCl3,δ(ppm));1.71~1.79(4H,m)、2.05(3H,s)、3.78(3H,s)、4.07~4.12(2H,t,J=6.23Hz)、4.15~4.20(2H,t,J=6.23Hz).
Claims (25)
- 加水分解酵素の存在下で、一般式(1):
で示される対称カーボネート化合物と、一般式(2):
R2及びR3は、それぞれ独立して、置換基を有していてもよい1価の炭化水素基(ここで、R2及びR3における炭化水素基は、エーテル結合、チオエーテル結合、アミド結合、カルボニル結合及びエステル結合からなる群より選択される結合基により中断されていてもよい)であるか、あるいは
R2及びR3は、互いに結合してZであり、Zは、置換基を有していてもよい2価の炭化水素基(ここで、Zにおける炭化水素基は、エーテル結合、チオエーテル結合、アミド結合、カルボニル結合及びエステル結合からなる群より選択される結合基により中断されていてもよい)であるが、
ただし、R2は、一般式(1)のR1と同一ではなく、かつ一般式(2)に含まれるエステル結合は全部で2個以下とする〕
で示されるエステル化合物とを反応させて、一般式(3):
R1は、前記で定義されたとおりであり、
R2’は、R2であるが、
ただし、R2及びR3が、互いに結合してZである場合、R2’は、-Z-C(=O)-O-R1である))
で示される非対称カーボネート化合物を得ることを特徴とする、非対称カーボネート化合物の製造方法。 - 加水分解酵素の存在下で、一般式(1):
で示される対称カーボネート化合物と、一般式(2a):
R2a及びR3aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基(ここで、R2a及びR3aにおける炭化水素基は、エーテル結合、チオエーテル結合、アミド結合、カルボニル結合及びエステル結合からなる群より選択される結合基により中断されていてもよい)であるが、
ただし、R2aは、一般式(1)のR1と同一ではなく、かつ一般式(2a)に含まれるエステル結合は全部で2個以下とする〕
で示されるエステル化合物とを反応させて、一般式(3a):
で示される非対称カーボネート化合物を得る、請求項1記載の非対称カーボネート化合物の製造方法。 - エステル交換化合物の留去が、0.13kPa以上、101.3kPa未満の反応圧力にて、行われることを特徴とする、請求項3記載の非対称カーボネート化合物の製造方法。
- R1及びR2aが、互いに異なり、それぞれ炭素原子数1~6の直鎖状アルキル基、炭素原子数3~6の分岐鎖状アルキル基又は炭素原子数3~6のシクロアルキル基である、請求項2~4のいずれか1項に記載の非対称カーボネート化合物の製造方法。
- R1が、メチル、エチル、n-プロピル、イソプロピル、n-ブチル、s-ブチル、イソブチル、t-ブチル又はベンジルである、請求項2~5のいずれか1項に記載の非対称カーボネート化合物の製造方法。
- R1が、メチル又はエチルである、請求項2~6のいずれか1項に記載の非対称カーボネート化合物の製造方法。
- 加水分解酵素の存在下で、一般式(1):
で示される対称カーボネート化合物と、一般式(5a):
R4a及びR5aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基であり、
Xは、置換基を有していてもよい2価の炭化水素基(ここで、炭化水素基は、エーテル結合、チオエーテル結合、アミド結合及びカルボニル結合からなる群より選択される結合基により中断されていてもよい)である〕
で示されるエステル化合物とを反応させて、一般式(6a):
R6は、R4a又はR5aであり、
R1、X、R4a及びR5aは、前記のとおりである)
で示される非対称カーボネート化合物を得る、請求項1記載の非対称カーボネート化合物の製造方法。 - R4a及びR5aが、互いに独立して、炭素原子数1~6の直鎖状アルキル基、炭素原子数3~6の分岐鎖状アルキル基又は炭素原子数3~6のシクロアルキル基であり、
Xが、炭素数1~6のアルキレン基又は炭素数1~6のアルケニレン基、又はエーテル結合により中断されている炭素原子数2~6の直鎖状アルキレン基である、請求項8記載の非対称カーボネート化合物の製造方法。 - 加水分解酵素の存在下で、一般式(1):
で示される対称カーボネート化合物と、一般式(5a):
R4a及びR5aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基であり、
Xは、置換基を有していてもよい2価の炭化水素基(ここで、炭化水素基は、エーテル結合、チオエーテル結合、アミド結合及びカルボニル結合からなる群より選択される結合基により中断されていてもよい)である〕
で示されるエステル化合物とを反応させて、一般式(7a):
で示される非対称カーボネート化合物を得る、請求項1記載の非対称カーボネート化合物の製造方法。 - 加水分解酵素の存在下で、一般式(1):
で示される対称カーボネート化合物と、一般式(8a):
R7a及びR8aは、それぞれ独立して、置換基を有していてもよい1価の炭化水素基であり、
Yは、置換基を有していてもよい2価の炭化水素基(ここで、炭化水素基は、エーテル結合、チオエーテル結合、アミド結合及びカルボニル結合からなる群より選択される結合基により中断されていてもよい)である〕
で示されるエステル化合物とを反応させて、一般式(9a):
R10aは、R7a又はR8aであり、
R1、R7a及びR8aは、前記のとおりである)
で示される非対称カーボネート化合物を得る、請求項1記載の非対称カーボネート化合物の製造方法。 - 加水分解酵素の存在下で、一般式(1):
で示される対称カーボネート化合物と、一般式(10):
で示される環状のエステル化合物とを反応させて、一般式(11):
で示される非対称カーボネート化合物を得る、請求項1に記載の非対称カーボネート化合物の製造方法。 - 一般式(10)で示される環状のエステル化合物が、δ-バレロラクトン、β-プロピオラクトン又はε-カプロラクトンである、請求項12に記載の非対称カーボネート化合物の製造方法。
- 加水分解酵素が、プロテアーゼ、エステラーゼ及びリパーゼからなる群より選択される少なくとも1種の加水分解酵素である、請求項1~13のいずれか1項に記載の非対称カーボネート化合物の製造方法。
- 加水分解酵素が、リパーゼである、請求項14に記載の非対称カーボネート化合物の製造方法。
- 加水分解酵素が、カンジダ・アンタークティカ(Candida antarctica)を起源とするリパーゼである、請求項15に記載の非対称カーボネート化合物の製造方法。
- 有機溶媒を使用することを特徴とする、請求項1~16のいずれか1項に記載の非対称カーボネート化合物の製造方法。
- 有機溶媒が、シクロヘキサン、トルエン及びt-ブチルメチルエーテルからなる群より選択される少なくとも1種の有機溶媒である、請求項17記載の非対称カーボネート化合物の製造方法。
- 一般式(1)で示される対称カーボネート化合物の量が、一般式(2)で示されるエステル化合物1モルに対して、0.1~100モルである、請求項1~18
のいずれか1項に記載の非対称カーボネート化合物の製造方法。 - 反応温度が0~130℃である、請求項1~19のいずれか1項に記載の非対称カーボネート化合物の製造方法。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009553490A JP5402646B2 (ja) | 2008-02-14 | 2009-02-16 | 非対称カーボネート化合物、及びその製造方法 |
EP09710722.1A EP2253710B1 (en) | 2008-02-14 | 2009-02-16 | Process for preparing asymmetrical carbonate compounds |
ES09710722.1T ES2618255T3 (es) | 2008-02-14 | 2009-02-16 | Compuesto de carbonato asimétrico y procedimiento para preparar el mismo |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008-032509 | 2008-02-14 | ||
JP2008032509 | 2008-02-14 | ||
JP2008084171 | 2008-03-27 | ||
JP2008-084171 | 2008-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009102069A1 true WO2009102069A1 (ja) | 2009-08-20 |
Family
ID=40957098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2009/052586 WO2009102069A1 (ja) | 2008-02-14 | 2009-02-16 | 非対称カーボネート化合物、及びその製造方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2253710B1 (ja) |
JP (1) | JP5402646B2 (ja) |
ES (1) | ES2618255T3 (ja) |
WO (1) | WO2009102069A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011122520A1 (ja) * | 2010-03-29 | 2011-10-06 | 宇部興産株式会社 | ポリカーボネートジオールジアクリレートの製造方法及び高純度のポリカーボネートジオールジアクリレート |
JP2015530972A (ja) * | 2012-07-13 | 2015-10-29 | ソルヴェイ(ソシエテ アノニム) | 三重結合を有するフッ化カルボニル化合物、その製造方法、及びその使用 |
WO2018198618A1 (ja) * | 2017-04-28 | 2018-11-01 | 宇部興産株式会社 | 非水電解液及びそれを用いた蓄電デバイス |
JP2020517064A (ja) * | 2017-04-10 | 2020-06-11 | メルク パテント ゲーエムベーハー | 有機機能材料の調合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09270270A (ja) * | 1996-04-02 | 1997-10-14 | Sony Corp | 非水電解液二次電池 |
JP2000344718A (ja) * | 1999-06-04 | 2000-12-12 | Mitsubishi Chemicals Corp | 非対称炭酸エステルの製造方法 |
JP2001002624A (ja) * | 1999-06-16 | 2001-01-09 | Mitsubishi Chemicals Corp | 非対称ジアルキルカーボネートの製造方法 |
US20020102671A1 (en) * | 2001-01-26 | 2002-08-01 | Janda Kim D. | Synthesis of B-keto esters |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4332744A (en) * | 1981-01-13 | 1982-06-01 | The United States Of America As Represented By The Secretary Of The Navy | Unsymmetrical polynitrocarbonates and methods of preparation |
DE4226043A1 (de) * | 1992-08-06 | 1994-02-10 | Haarmann & Reimer Gmbh | Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen |
US5962720A (en) * | 1997-05-29 | 1999-10-05 | Wilson Greatbatch Ltd. | Method of synthesizing unsymmetric organic carbonates and preparing nonaqueous electrolytes for alkali ion electrochemical cells |
JP2000281630A (ja) * | 1999-03-26 | 2000-10-10 | Mitsubishi Chemicals Corp | 非対称ジアルキルカーボネートの製造方法 |
-
2009
- 2009-02-16 JP JP2009553490A patent/JP5402646B2/ja not_active Expired - Fee Related
- 2009-02-16 EP EP09710722.1A patent/EP2253710B1/en not_active Not-in-force
- 2009-02-16 ES ES09710722.1T patent/ES2618255T3/es active Active
- 2009-02-16 WO PCT/JP2009/052586 patent/WO2009102069A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09270270A (ja) * | 1996-04-02 | 1997-10-14 | Sony Corp | 非水電解液二次電池 |
JP2000344718A (ja) * | 1999-06-04 | 2000-12-12 | Mitsubishi Chemicals Corp | 非対称炭酸エステルの製造方法 |
JP2001002624A (ja) * | 1999-06-16 | 2001-01-09 | Mitsubishi Chemicals Corp | 非対称ジアルキルカーボネートの製造方法 |
US20020102671A1 (en) * | 2001-01-26 | 2002-08-01 | Janda Kim D. | Synthesis of B-keto esters |
Non-Patent Citations (5)
Title |
---|
HACKING M. ET AL.: "Lipase catalyzed reactions of aliphatic and arylaliphatic carbonic acid esters.", JOURNAL OF MOLECULAR CATALYSIS B: ENZYMATIC, vol. 9, no. 4-6, 2000, pages 201 - 208, XP009114319 * |
J. AM. CHEM. SOC., vol. 122, no. 8, 2000, pages 1565 - 1571 |
MANDAI T. ET AL.: "Tandem Pd-catalyzed carbonylation and intramolecular ene reaction of 1-(2-methoxycarbonylethynyl)-4-alkenyl methyl carbonates.", TETRAHEDRON LETTERS, vol. 35, no. 31, 1994, pages 5701 - 5704, XP008140698 * |
POHLMAN M. ET AL.: "Allylic alkylation versus Michael induced ring closure: chelated enolates as versatile nucleophiles.", JOURNAL OF ORGANIC CHEMISTRY, vol. 69, no. 20, 2004, pages 6909 - 6912, XP008140697 * |
See also references of EP2253710A4 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011122520A1 (ja) * | 2010-03-29 | 2011-10-06 | 宇部興産株式会社 | ポリカーボネートジオールジアクリレートの製造方法及び高純度のポリカーボネートジオールジアクリレート |
US8901254B2 (en) | 2010-03-29 | 2014-12-02 | Ube Industries, Ltd. | Process for preparing polycarbonate diol diacrylate and high-purity polycarbonate diol diacrylate |
JP5708641B2 (ja) * | 2010-03-29 | 2015-04-30 | 宇部興産株式会社 | ポリカーボネートジオールジアクリレートの製造方法及び高純度のポリカーボネートジオールジアクリレート |
JP2015530972A (ja) * | 2012-07-13 | 2015-10-29 | ソルヴェイ(ソシエテ アノニム) | 三重結合を有するフッ化カルボニル化合物、その製造方法、及びその使用 |
JP2020517064A (ja) * | 2017-04-10 | 2020-06-11 | メルク パテント ゲーエムベーハー | 有機機能材料の調合物 |
JP2022184971A (ja) * | 2017-04-10 | 2022-12-13 | メルク パテント ゲーエムベーハー | 有機機能材料の調合物 |
JP7200128B2 (ja) | 2017-04-10 | 2023-01-06 | メルク パテント ゲーエムベーハー | 有機機能材料の調合物 |
WO2018198618A1 (ja) * | 2017-04-28 | 2018-11-01 | 宇部興産株式会社 | 非水電解液及びそれを用いた蓄電デバイス |
JPWO2018198618A1 (ja) * | 2017-04-28 | 2020-05-14 | 宇部興産株式会社 | 非水電解液及びそれを用いた蓄電デバイス |
JP7082613B2 (ja) | 2017-04-28 | 2022-06-08 | Muアイオニックソリューションズ株式会社 | 非水電解液及びそれを用いた蓄電デバイス |
Also Published As
Publication number | Publication date |
---|---|
JPWO2009102069A1 (ja) | 2011-06-16 |
JP5402646B2 (ja) | 2014-01-29 |
EP2253710B1 (en) | 2016-12-07 |
EP2253710A1 (en) | 2010-11-24 |
ES2618255T3 (es) | 2017-06-21 |
EP2253710A4 (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2294236T3 (es) | Procedimiento para la preparacion de esteres sustituidos con 3,5-dihidroxi como intermedios para producir derivados de acido 2-(6-hiximetil)-1,3-dioxan-4-il) acetico opticamente activos. | |
CA2408004C (en) | Process for the preparation of dihydroxy esters and derivatives thereof | |
EP0915866A1 (en) | Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid | |
US20100087525A1 (en) | Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester | |
JP2010088455A (ja) | 光学活性3−ヒドロキシプロピオン酸エステル誘導体の製造法 | |
JP5402646B2 (ja) | 非対称カーボネート化合物、及びその製造方法 | |
JP5803675B2 (ja) | カルバメート化合物の製造方法 | |
BRPI0718792A2 (pt) | Compostos orgânicos | |
WO2005073388A1 (ja) | 光学活性1−置換—2—メチルピロリジンおよびその中間体の製造法 | |
JP4800482B2 (ja) | (2s,4r,9s)−オクタヒドロ−1h−インドール−2−カルボン酸の製法及びその中間体 | |
JP5333720B2 (ja) | オリゴアルキレンカーボネート化合物、及びポリアルキレンカーボネート化合物の製造方法 | |
JP5589266B2 (ja) | ポリ(アルキレンカーボネート)化合物の製造方法 | |
JP2006063001A (ja) | 光学活性β−ブチロラクトンの製造方法 | |
KR101156495B1 (ko) | 에스시탈로프람의 제조에 사용할 수 있는 중간체들의 분리방법 | |
JP3901093B2 (ja) | 光学分割剤およびそれを用いるアルコールの光学分割方法 | |
US20050014818A1 (en) | Process for producing optically active chroman derivative and intermediate | |
CA2841089A1 (en) | Production of optically pure propane-1,2-diol | |
JPWO2002070726A1 (ja) | 光学活性なプロポキシアニリン誘導体の製造方法 | |
ES2353131T3 (es) | Proceso para producir derivados de ácido 2-[6-(hidroximetil)-1,3-dioxan-4-il]acético. | |
JP2000063321A (ja) | 光学純度の高い長鎖β−ヒドロキシカルボン酸の製造方法 | |
JP2013031436A (ja) | カルバメート化合物の製造方法 | |
JP2006000006A (ja) | 光学活性2−アルキル−d−システインエステルの製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09710722 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2009553490 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2009710722 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009710722 Country of ref document: EP |